<SEC-DOCUMENT>0000700841-21-000005.txt : 20210115
<SEC-HEADER>0000700841-21-000005.hdr.sgml : 20210115
<ACCEPTANCE-DATETIME>20210115162200
ACCESSION NUMBER:		0000700841-21-000005
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20210115
DATE AS OF CHANGE:		20210115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RCM TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0000700841
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HELP SUPPLY SERVICES [7363]
		IRS NUMBER:				951480559
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0102

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-252148
		FILM NUMBER:		21532366

	BUSINESS ADDRESS:	
		STREET 1:		2500 MCCLELLAN AVENUE
		STREET 2:		STE 350
		CITY:			PENNSAUKEN
		STATE:			NJ
		ZIP:			08109-4613
		BUSINESS PHONE:		8563564500

	MAIL ADDRESS:	
		STREET 1:		2500 MCCLELLAN AVENUE
		STREET 2:		STE 350
		CITY:			PENNSAUKEN
		STATE:			NJ
		ZIP:			08109-4613

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RCM TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>forms3011521.htm
<DESCRIPTION>FORM S-3 1/15/21
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: RCM Technologies, Inc.
         Document created using EDGARfilings PROfile 7.2.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">As filed with the Securities and Exchange Commission on January 15, 2021.</div>
    <div style="text-align: right; line-height: 9.1pt; font-size: 8pt; font-weight: bold;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8df7bf6ff69142b28aac7c4ba37a4263">

          <tr>
            <td style="width: 100%; vertical-align: top; text-align: right; font-size: 6pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;<font style="font-weight: bold;">Registration No.&#160;333&#8209;</font></td>
          </tr>

      </table>
    </div>
    <div style="line-height: 14.4pt;">
      <div style="line-height: 1.15pt;"><br style="line-height: 1.15pt;">
      </div>
    </div>
    <div style="text-align: center; line-height: 11.4pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; line-height: 11.4pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; line-height: 8pt; margin-bottom: 4pt; font-size: 8pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div style="text-align: center; line-height: 11.4pt; font-weight: bold;">FORM S&#8209;3</div>
    <div style="text-align: center; line-height: 8pt; font-size: 8pt; font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; line-height: 8pt; font-size: 8pt; font-weight: bold;">UNDER</div>
    <div style="text-align: center; line-height: 8pt; margin-bottom: 4pt; font-size: 8pt; font-weight: bold;">THE SECURITIES ACT OF&#160;1933</div>
    <div style="text-align: center; line-height: 11.4pt; font-weight: bold;">RCM TECHNOLOGIES,&#160;INC.</div>
    <div style="text-align: center; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt;">(Exact Name of Registrant as Specified in Its Charter)</div>
    <table cellspacing="0" cellpadding="0" id="zd4e7595a9f1943a2bed24c06fa1210b4" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-size: 6pt;"><font style="font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nevada</font><br>
              (State or Other Jurisdiction of<br>
              Incorporation or Organization)</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; line-height: 9.1pt; font-size: 6pt;"><font style="font-weight: bold;">95-1480559</font><br>
              (I.R.S. Employer<br>
              Identification Number)</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">2500 McClellan Avenue, Suite 350</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">Pennsauken, NJ 08109-4613</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">(856)&#160;356-4500</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt;">(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices)</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; margin-top: 4pt; font-size: 6pt; font-weight: bold;">Kevin D. Miller</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">Chief Financial Officer</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">RCM Technologies,&#160;Inc.</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">2500 McClellan Avenue, Suite 350</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">Pennsauken, NJ 08109-4613</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">(856)&#160;356-4500</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt;">&#160;(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)</div>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="z850d10187b974e75829186ecb3519aa9" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Copies to:</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Justin W. Chairman, Esquire<br>
              Morgan, Lewis&#160;&amp; Bockius&#160;LLP<br>
              1701 Market Street<br>
              Philadelphia, PA 19103<br>
              (215)&#160;963-5000</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; margin-top: 4pt; font-size: 6pt; font-weight: bold;">Approximate date of commencement of proposed sale to the public:</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-align: center; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt; font-weight: bold;">From time to time after this registration statement becomes effective.</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-indent: 36pt; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt;">If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9633;</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-indent: 36pt; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt;">If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933,
      other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.&#160; &#8999;</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-indent: 36pt; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt;">If this form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check the following box and list
      the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160; &#9633;</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-indent: 36pt; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt;">If this form is a post&#8209;effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration
      statement number of the earlier effective registration statement for the same offering.&#160; &#9633;</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-indent: 36pt; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt;">If this form is a registration statement pursuant to General Instruction&#160;I.D. or a post&#8209;effective amendment thereto that shall become effective upon filing with the
      Commission pursuant to Rule&#160;462(e) under the Securities Act, check the following box.&#160; &#9633;</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-indent: 36pt; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt;">If this form is a post&#8209;effective amendment to a registration statement filed pursuant to General Instruction&#160;I.D. filed to register additional securities or
      additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box.&#160; &#9633;</div>
    <font style="font-size: 6pt;"> </font>
    <div style="text-indent: 36pt; line-height: 9.1pt; margin-bottom: 4pt; font-size: 6pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non&#8209;accelerated filer, a smaller reporting company, or an
      emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b&#8209;2 of the Exchange Act.</div>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="zc918642510594c879d63fa5e12b72127" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 26.16%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-size: 6pt;">Large&#160;accelerated&#160;filer&#160;&#9633;</div>
          </td>
          <td style="width: 21.54%; vertical-align: top;">
            <div style="text-align: center; line-height: 9.1pt; font-size: 6pt;">Accelerated&#160;filer&#160;&#9633;</div>
          </td>
          <td style="width: 24.62%; vertical-align: top;">
            <div style="text-align: center; line-height: 9.1pt; font-size: 6pt;">Non&#8209;accelerated&#160;filer&#160;&#8999;</div>
          </td>
          <td style="width: 27.68%; vertical-align: top;">
            <div style="text-align: right; line-height: 9.1pt; font-size: 6pt;">Smaller&#160;reporting&#160;company&#160;&#8999;</div>
            <div style="text-align: right; line-height: 9.1pt; font-size: 6pt;">Emerging&#160;growth&#160;company&#160;&#9633;</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <div style="text-indent: 36pt; line-height: 9.1pt; margin-top: 4pt; margin-bottom: 4pt; font-size: 6pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
      any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act.&#160; &#9633;</div>
    <div style="text-align: center; line-height: 8pt; margin-bottom: 4pt; font-size: 8pt; font-weight: bold;">CALCULATION OF REGISTRATION FEE</div>
    <div style="text-align: center; line-height: 8pt; margin-bottom: 4pt; font-size: 8pt; font-weight: bold;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb9a129780086414bbee6f04bd71e3165">

          <tr>
            <td style="width: 42.15%; vertical-align: bottom; border-right: #000000 2px solid; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt; font-weight: bold;">Title of each Class of Securities<br>
                to be Registered</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt; font-weight: bold;">Amount to be<br>
                Registered(1)</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt; font-weight: bold;">Proposed Maximum<br>
                Offering Price Per<br>
                unit(1)(2)</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt; font-weight: bold;">Proposed Maximum<br>
                Aggregate Offering<br>
                Price(1)(3)</div>
            </td>
            <td style="width: 14.46%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt; font-weight: bold;">Amount of<br>
                Registration Fee(1)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.15%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">Common Stock, $0.05 par value per share(4)(10)</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.46%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.15%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">Preferred Stock, $0.001 par value per share(5)(10)</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.46%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.15%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">Warrants(6)(10)</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.46%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.15%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">Rights to purchase common stock, preferred stock or units(7)(9)</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.46%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.15%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">Units(8)(9)</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
            <td style="width: 14.46%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">&#8212;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.15%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 4px double;">
              <div style="text-indent: -10pt; margin-left: 10pt; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">TOTAL</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 4px double;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">$25,000,000</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 4px double;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">100%</div>
            </td>
            <td style="width: 14.47%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 4px double;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">$25,000,000(10)</div>
            </td>
            <td style="width: 14.46%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 4px double;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 6pt;">$ 2,728 (11)</div>
            </td>
          </tr>

      </table>
    </div>
    <font style="font-size: 6pt;"> </font><font style="font-size: 6pt;"> </font><font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="z9abd12f7b6d740ecbd42bf64850a81af" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt; margin-top: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(1)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">Not specified as to each class of securities to be registered pursuant to General Instruction&#160;II.D. to Form&#160;S&#8209;3.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="zb1e3ba000e374925819e44f2616f4b54" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(2)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">The proposed maximum offering price per unit will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="z76027d545fcc40f4b48c492828c5af24" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(3)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">Estimated solely for the purpose of calculating the registration fee pursuant to Rule&#160;457(o).</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="z32873c16be4f434f862a887778b26c65" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(4)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">Subject to note&#160;(10) below, there is being registered an indeterminate number of shares of common stock.&#160; Includes rights to acquire common stock or preferred stock of the Company under any shareholder rights plan
              then in effect, if applicable under the terms of any such plan.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="z1e2a17076f7a4a8a9889a7926fa5991e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(5)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">Subject to note&#160;(10) below, there is being registered an indeterminate number of shares of preferred stock.&#160; Includes rights to acquire common stock or preferred stock of the Company under any shareholder rights
              plan then in effect, if applicable under the terms of any such plan.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="z6c748c637bb84319adea0997dea43b60" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(6)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">Subject to note&#160;(10) below, there is being registered hereunder an indeterminate amount and number of warrants. The warrants may represent the right to purchase shares of common stock or shares of preferred stock.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="zd3ead95f18564e4c8f9f95716738dbcf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(7)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">Subject to note&#160;(10) below, there is being registered an indeterminate number of rights that may represent a right to purchase common shares, preferred shares or units.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="z9322e8facec84811b64b41f4cb487a78" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(8)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">Subject to note&#160;(10) below, there is being registered an indeterminate number of units. Each unit will be issued under a unit agreement and will represent an interest in a combination of one or more of the
              securities registered hereunder.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="zf415a5de1255405bba1959c8f03a90be" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(9)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">Subject to note&#160;(10) below, this registration statement also covers an indeterminate amount of securities as may be issued in exchange for, or upon conversion or exercise of, as the case may be, the shares of
              preferred stock or warrants registered hereunder. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. No separate consideration will be received for any securities registered
              hereunder that are issued in exchange for, or upon conversion of, as the case may be, the shares of preferred stock or warrants.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="z7e0d110b5d774a43ad1d8e933b8d0d3f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(10)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">In no event will the aggregate initial offering price of all securities issued from time to time pursuant to the prospectus contained in this registration statement exceed $25,000,000 or the equivalent thereof in
              one or more foreign currencies or foreign currency units. Such amount represents the offering price of any shares of common stock or shares of preferred stock, the issue price of any warrants, the exercise price of any securities issuable
              upon the exercise of warrants, and the issue price of any securities issuable upon the exercise of rights. Any offering of securities denominated other than in United States dollars will be treated as the equivalent of United States dollars
              based on the exchange rate applicable to the purchase of such securities at the time of initial offering. The securities registered hereunder may be sold separately or as units with other securities registered hereunder.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <table cellspacing="0" cellpadding="0" id="z969da54fbec14178be5761e4d9209d05" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 4pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-size: 6pt;">(11)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 6pt;">The registration fee has been calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended.</div>
          </td>
        </tr>

    </table>
    <font style="font-size: 6pt;"> </font>
    <div style="text-indent: 36pt; line-height: 9.1pt; font-size: 6pt; font-weight: bold;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file&#160;a
      further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933, as amended, or until this registration statement shall become effective on
      such date as the Securities and Exchange Commission, acting pursuant to such Section&#160;8(a), may determine.</div>
    <div style="line-height: 14.4pt;">
      <div style="line-height: 9.1pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbe5e04738df94c33bb8ccdce551d9a9e">

            <tr>
              <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter"></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="line-height: 11.4pt; margin-bottom: 5pt; font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(255, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The
      information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these
      securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 5pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(255, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Subject to Completion, Dated January 15, 2021</div>
    <div style="line-height: 13.7pt;"><br>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 5pt; font-weight: bold;">PROSPECTUS</div>
    <div style="line-height: 11.4pt; margin-bottom: 2pt;">
      <div style="line-height: 13.7pt; margin-left: 243pt;"><img width="210" height="58" src="image0.jpg"></div>
    </div>
    <div style="line-height: 14.8pt; margin-bottom: 4pt;"><br style="line-height: 14.8pt;">
    </div>
    <div style="text-align: center; line-height: 14.8pt; margin-bottom: 4pt; font-size: 12pt; font-weight: bold;">$25,000,000</div>
    <div style="text-align: center; line-height: 14.8pt; margin-bottom: 1pt; font-size: 12pt; font-weight: bold;">RCM TECHNOLOGIES,&#160;INC.</div>
    <div style="text-align: center; line-height: 14.8pt; font-size: 12pt; font-weight: bold;">Common Stock</div>
    <div style="text-align: center; line-height: 14.8pt; font-size: 12pt; font-weight: bold;">Preferred Stock</div>
    <div style="text-align: center; line-height: 14.8pt; font-size: 12pt; font-weight: bold;">Warrants</div>
    <div style="text-align: center; line-height: 14.8pt; font-size: 12pt; font-weight: bold;">Rights to Purchase Common Stock, Preferred Stock or Units</div>
    <div style="text-align: center; line-height: 14.8pt; margin-bottom: 5pt; font-size: 12pt; font-weight: bold;">Units</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 5pt;">We may offer and sell from time to time our shares of common stock, shares of preferred stock, warrants and rights to purchase common stock, preferred stock or units, as well as
      units that include any of these securities. We may sell any combination of these securities in one or more offerings with an aggregate offering price of up to $25,000,000.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 5pt;">This prospectus provides you with a general description of the securities we may offer. Each time we offer securities pursuant to this prospectus, we will provide a prospectus
      supplement containing specific terms of the particular offering together with this prospectus. You should read this prospectus and the applicable prospectus supplement carefully before you invest in any securities. The prospectus supplement also may
      add, update or change information contained in this prospectus. <font style="font-weight: bold;">This prospectus may not be used to offer and sell securities unless accompanied by the applicable prospectus supplement.</font></div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 5pt;">Our common stock is listed on the Nasdaq Capital Market under the symbol &#8220;RCMT.&#8221; On January 14, 2021, the closing price of our common stock was $2.25.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 5pt;">This prospectus is subject to the offering limits in General Instruction I.B.6 of Form S-3. The aggregate market value of our common stock held by non-affiliates calculated
      pursuant to General Instruction I.B.6 of Form S-3 is $18.2 million which was calculated based on 7.5 million shares of our common stock outstanding held by non-affiliates and at a price of $2.43 per share, the closing price of our common stock on
      December 28, 2020. During the last twelve months, we have made no offers of our common stock for sale pursuant to General Instruction I.B.6 of Form S-3.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 5pt; font-weight: bold;">Investing in our securities involves significant risks. We strongly recommend that you read carefully the risks we describe in this prospectus and in any
      accompanying prospectus supplement, as well as the risk factors that are incorporated by reference into this prospectus from our filings made with the Securities and Exchange Commission. See &#8220;Risk Factors&#8221; on page&#160;4 of this prospectus.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 5pt;">We may sell the securities directly or to or through underwriters or dealers, and also to other purchasers or through agents. The names of any underwriters or agents that are
      included in a sale of securities to you, and any applicable commissions or discounts, will be stated in an accompanying prospectus supplement. In addition, the underwriters, if any, may over&#8209;allot a portion of the securities.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 5pt; font-weight: bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy
      or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 1pt;">The date of this prospectus is January 15, 2021</div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 1pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageFooter"></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 1pt;"> <br>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 1pt;"> <font style="font-weight: bold;">TABLE OF CONTENTS</font></div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 1pt;"> <br>
    </div>
    <table align="center" cellspacing="0" cellpadding="0" border="0" id="z8f4823f90afe45c0ad7e318c8341483f" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">ABOUT THIS PROSPECTUS</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">RCM TECHNOLOGIES, INC</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">SPECIAL NOTE REGARDING FORWARD&#8209;LOOKING STATEMENTS</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">RISK FACTORS</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">USE OF PROCEEDS</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">DESCRIPTION OF CAPITAL STOCK</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">5</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">DESCRIPTION OF WARRANTS</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">10</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">DESCRIPTION OF RIGHTS</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">18</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">DESCRIPTION OF UNITS</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">19</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">PLAN OF DISTRIBUTION</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">20</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">LEGAL MATTERS</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">22</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">EXPERTS</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">22</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">WHERE YOU CAN FIND MORE INFORMATION</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">22</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">INFORMATION INCORPORATED BY REFERENCE</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">22</div>
          </td>
        </tr>
        <tr>
          <td style="width: 95.86%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">DISCLOSURE OF COMMISSION&#8217;S POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITY</div>
          </td>
          <td style="width: 4.14%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">23</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 11.4pt; margin-top: 12pt; margin-bottom: 12pt; font-weight: bold;">ABOUT THIS PROSPECTUS</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;), using a &#8220;shelf&#8221; registration process. Under this shelf
      registration process, we may offer and sell from time to time any combination of the securities described in this prospectus in one or more offerings in amounts, at prices and on terms that we determine at the time of the offering, with an aggregate
      offering price of up to $25,000,000. This prospectus provides you with a general description of the securities we may offer. Each time we offer securities under this registration statement we will provide a prospectus supplement that describes the
      terms of the relevant offering. The prospectus supplement also may add, update or change information contained in this prospectus. Before making an investment decision, you should read carefully both this prospectus and any prospectus supplement
      together with the documents incorporated by reference into this prospectus as described below under the heading &#8220;Information Incorporated by Reference.&#8221;</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The registration statement that contains this prospectus, including the exhibits to the registration statement and the information incorporated by reference, provides additional
      information about us and our securities. That registration statement can be read at the SEC website (www.sec.gov), as discussed below under the heading &#8220;Where You Can Find More Information.&#8221;</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">You should rely only on the information provided in the registration statement, this prospectus and in any prospectus supplement, including the information incorporated by
      reference. We have not authorized anyone to provide you with different information. You should not assume that the information in this prospectus or any supplement to this prospectus is accurate at any date other than the date indicated on the cover
      page of these documents or the filing date of any document incorporated by reference, regardless of its time of delivery. We are not making an offer to sell the securities in any jurisdiction where the offer or sale is not permitted.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We may sell our securities to or through underwriters, initial purchasers, dealers or agents, directly to purchasers or through a combination of any of these methods of sale, as
      designated from time to time. We and our agents reserve the sole right to accept or reject in whole or in part any proposed purchase of our securities. An applicable prospectus supplement, which we will provide each time we offer the securities, will
      set forth the names of any underwriters, initial purchasers, dealers or agents involved in the sale of our securities, and any related fee, commission or discount arrangements. See &#8220;Plan of Distribution.&#8221;</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The terms &#8220;RCM,&#8221; the &#8220;Company,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; and &#8220;we,&#8221; as used in this prospectus, refer to RCM Technologies,&#160;Inc., unless we state otherwise or the context indicates otherwise.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter"></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">RCM TECHNOLOGIES,&#160;INC.</div>
    <div style="line-height: 14.4pt;">
      <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Overview</div>
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We are a premier provider of business and technology solutions designed to enhance and maximize the operational performance of our customers through the adaptation and
        deployment of advanced engineering, specialty health care and information technology services.&#160; We have been an innovative leader in the design, development, and delivery of these services to commercial and government sectors for over 40 years.&#160;
        Over the years, we have developed and assembled an attractive, diverse and extensive portfolio of capabilities, service offerings and delivery options, established a proven record of performance and credibility, and built an efficient pricing
        structure.&#160; This combination offers clients a compelling value proposition with the potential to substantially accelerate the successful attainment of their business objectives.</div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
    </div>
    <div style="line-height: 14.4pt;">
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">RCM consists of three operating segments: Engineering, Specialty Health Care and Information Technology Services.&#160; Our Engineering segment provides engineering and design,
        engineering analysis, technical writing and technical support services, process and industrial, Engineer, Procure and Construction Management (&#8220;EPC&#8221;) as well as Demand Side Management/Energy Conservation Services.&#160;&#160; Our Specialty Health Care
        Services segment provides the staffing of health care professionals, primarily health information management professionals, nurses, paraprofessionals, physicians and therapists.&#160; Our Information Technology, or IT, segment provides enterprise
        business solutions, application services, infrastructure solutions, competitive advantage &amp; productivity solutions, life sciences solutions and other selected vertical market specific offerings.</div>
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We service some of the largest national and international companies in North America as well as a lengthy roster of Fortune 1000 and mid-sized businesses in such industries as
        Aerospace/Defense, Educational Institutions, Energy, Financial Services, Health Care, Life Sciences, Manufacturing &amp; Distribution, the Public Sector and Technology.&#160; We believe we offer a range of solutions that foster long-term client
        relationships, affords cross-selling opportunities, and minimizes our dependence on any single technology or industry sector.&#160; We sell and deliver our services through a network of approximately 29 offices in selected regions throughout North
        America and Serbia.</div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
    </div>
    <div style="line-height: 14.4pt;">
      <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Corporate Information</div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
    </div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;"><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>We were incorporated in the state of Nevada in 1971. Our principal executive offices
      are located at 2500 McClellan Avenue, Suite 350, Pennsauken, NJ 08109 and our telephone number is (856)&#160;356-4500. Our website address is www.rcmt.com. The information contained on our website is not incorporated by reference into this prospectus, and
      you should not consider any information contained on, or that can be accessed through, our website as part of this prospectus or in deciding whether to purchase our common stock.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">SPECIAL NOTE REGARDING FORWARD&#8209;LOOKING STATEMENTS</div>
    <div style="line-height: 14.4pt;">
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">This prospectus, each prospectus supplement and the information incorporated by reference in this prospectus and each prospectus supplement contain forward-looking statements
        within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, which we refer to as the Securities Act, and Section&#160;21E of the Exchange Act of 1934, as amended, which we refer to as the Exchange Act, that involve a number of risks and
        uncertainties. Although our forward-looking statements reflect the good faith judgment of our management, these statements can only be based on facts and factors currently known by us. Consequently, these forward-looking statements are inherently
        subject to known and unknown risks, uncertainties and other factors that may cause actual results and outcomes may differ materially from results and outcomes discussed in the forward-looking statements.</div>
      <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt">&#160;</font>Forward-looking statements can generally be identified by the use of
        forward-looking terms such as &#8220;believe,&#8221; &#8220;hope,&#8221; &#8220;expect,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;seek,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;anticipate&#8221; and &#8220;continue,&#8221; or other comparable terms (including their use in the negative), or by
        discussions of future matters. These statements include but are not limited to statements under the captions &#8220;Business,&#8221; &#8220;Risk Factors&#8221; and &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; and in other
        sections included in any applicable prospectus supplement or incorporated by reference from our&#160;Annual Report on Form&#160;10-K&#160;and&#160;Quarterly Reports on Form&#160;10-Q, as applicable, as well as our other filings with the SEC. You should be aware that the
        occurrence of any of the events discussed under the heading &#8220;Risk Factors&#8221; in this prospectus, any applicable prospectus supplement and any documents incorporated by reference herein or therein could substantially harm our business, operating
        results and financial condition and that if any of these events occurs, it could adversely affect the value of an investment in our securities.</div>
      <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt">&#160;</font>The cautionary statements made in this prospectus are intended to be
        applicable to all related forward-looking statements wherever they may appear in this prospectus or in any prospectus supplement or any documents incorporated by reference herein or therein. We urge you not to place undue reliance on these
        forward-looking statements, which speak only as of the date they are made. Except as required by law, we assume no obligation to update our forward-looking statements, even if new information becomes available in the future.</div>
      <div style="line-height: 11.4pt; margin-bottom: 12pt;"> <br>
      </div>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">RISK FACTORS</div>
    <div style="line-height: 14.4pt;">
      <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;&#160;&#160;&#160;&#160;&#160;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt">&#160;</font>Investing in our securities involves a high degree of risk. You should
        carefully review the risks and uncertainties described under the heading &#8220;Risk Factors&#8221; contained in any applicable prospectus supplement and any related free writing prospectus, and under similar headings in our Annual Report on&#160;Form&#160;10-K for the
        year ended December&#160;28, 2019, as updated by our annual, quarterly and other reports and documents that are incorporated by reference into this prospectus, before deciding whether to purchase any of the securities being registered pursuant to the
        registration statement of which this prospectus is a part. Each of the risk factors could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment in our securities, and the
        occurrence of any of these risks might cause you to lose all or part of your investment.</div>
      <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt">&#160;</font>The prospectus supplement applicable to each type or series of securities
        we offer may contain a discussion of risks applicable to the particular types of securities that we are offering under that prospectus supplement. Prior to making a decision about investing in our securities, you should carefully consider the
        specific factors discussed under the caption &#8220;Risk Factors&#8221; in the applicable prospectus supplement, together with all of the other information contained in the prospectus supplement or appearing or incorporated by reference in this prospectus.
        These risks could materially affect our business, results of operations or financial condition and cause the value of our securities to decline. You could lose all or part of your investment. Additional risks not presently known to us or that we
        currently believe are immaterial may also significantly impair our business operations. Please also read carefully the section above titled &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</div>
      <div style="line-height: 15.4pt; margin-bottom: 12pt;"><br style="line-height: 15.4pt;">
      </div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">USE OF PROCEEDS</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We will retain broad discretion over the use of the net proceeds from the sale of the securities offered hereby. Except as described in any prospectus supplement or any related
      free writing prospectus that we may authorize to be provided to you, we currently intend to use the estimated net proceeds from the sale of the securities offered hereby for general corporate purposes, which may include capital expenditures, working
      capital and general and administrative expenses. We may also use a portion of the net proceeds to acquire or invest in businesses that are complementary to our own, although we have no current plans, commitments or agreements with respect to any
      acquisitions as of the date of this prospectus. We have not yet determined the amount of net proceeds to be used specifically for any of the foregoing purposes. We will set forth in the applicable prospectus supplement or free writing prospectus our
      intended use for the net proceeds received from the sale of any securities sold pursuant to the prospectus supplement or free writing prospectus.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">DESCRIPTION OF CAPITAL STOCK</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The description below of our capital stock and provisions of our Articles of Incorporation, as amended (the &#8220;Articles&#8221;), and our Amended and Restated Bylaws (the &#8220;Bylaws&#8221;), are
      summaries and are qualified by reference to the Articles and the Bylaws, and the applicable provisions of Nevada law.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">General</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The Articles authorize us to issue up to 40,000,000 shares of common stock, $0.05 par value per share, and 5,000,000 shares of preferred stock, $1.00 par value per share.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">As of January 14, 2021, there were 11,953,930 shares of common stock outstanding and no shares of preferred stock outstanding.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Common Stock</div>
    <div style="line-height: 14.4pt;">
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The holders of our common stock are entitled to one vote for every share standing in the name of the stockholder in the books of the Company on any matter submitted to the
        stockholders, including the election of directors. Under Nevada law, holders of the common stock do not have any preemptive rights to acquire any shares, treasury shares or securities convertible into such shares, if the shares or shares into which
        the convertible securities may be converted are upon issuance registered pursuant to section 12 of the Securities Exchange Act of 1934, as amended.&#160; Holders of the common stock do not have any cumulative voting rights. The holders of our common
        stock are entitled to receive dividends when, as and if declared by our board of directors out of legally available funds. Upon our liquidation or dissolution, the holders of common stock will be entitled to share ratably in those of our assets
        that are legally available for distribution to stockholders after payment of liabilities and subject to the prior rights of any holders of preferred stock then outstanding. All of the outstanding shares of common stock are fully paid and
        nonassessable. The rights, preferences and privileges of holders of common stock are subject to the rights of the holders of shares of any series of preferred stock that may be issued in the future.</div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
    </div>
    <div style="line-height: 14.4pt;">
      <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Blank Check Preferred Stock</div>
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We are authorized to issue up to 5,000,000 shares of preferred stock. Subject to limitations prescribed by Nevada law and the Articles, our board of directors has the
        authority, without further action by our stockholders, to designate one or more classes or series of preferred stock and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights granted to or imposed upon
        each such class or series, including dividend rights, conversion rights, voting rights, rights and terms of redemption, liquidation preference and sinking fund terms, any or all of which may be preferential to or greater than the rights of our
        common stock. The issuance of preferred stock may have the effect of delaying, deferring or preventing a change in control of our Company and may adversely affect the voting and other rights of the holders of our common stock, which could have an
        adverse impact on the market price of our common stock.</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Stockholder Rights Plan</div>
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Our Board of Directors approved and adopted a Rights Agreement, dated as of May 22, 2020 (the &#8220;Rights Agreement&#8221;), by and between the Company and American Stock Transfer &amp;
        Trust Company, LLC, as Rights Agent (the &#8220;Rights Agent&#8221;). Pursuant to the Rights Agreement, the Board declared a dividend of one preferred share purchase right (each, a &#8220;Right&#8221;) for each outstanding share of common stock of the Company. The Rights
        were distributable to stockholders of record as of the close of business on June 2, 2020, and one Right will also be issued together with each share of common stock issued by the Company after June 2, 2020, but before the Distribution Date (as
        defined in the Rights Agreement) (or the earlier redemption or expiration of the Rights) and, in certain circumstances, after the Distribution Date.</div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
    </div>
    <div style="line-height: 14.4pt;">
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Generally, the Rights Agreement works by substantially diluting any person or group that acquires beneficial ownership of ten percent (10%) or more of the shares of common
        stock without the approval of the Board. As a result, the overall effect of the Rights Agreement and the issuance of the Rights may be to render more difficult or discourage a merger, tender or exchange offer or other business combination involving
        the Company that is not approved by the Board. The Rights Agreement is not intended to interfere with any merger, tender or exchange offer or other business combination approved by the Board. Nor does the Rights Agreement prevent the Board from
        considering any offer that it considers to be in the best interest of its stockholders.</div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
    </div>
    <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Anti-Takeover Effects of Certain Provisions of the Articles and Bylaws and of Nevada Law</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Nevada law, the Articles and the Bylaws contain provisions that are intended to enhance the likelihood of continuity and stability in the composition of the Company&#8217;s board of
      directors and that could make it more difficult to acquire control of the Company by means of a tender offer, open market purchases, a proxy contest or otherwise. A description of these provisions is set forth below.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Nevada Anti-Takeover Statutes</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><u>Business Combinations Statutes</u></div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Nevada&#8217;s &#8220;combinations with interested stockholders&#8221; statutes (Nevada Revised Statutes (&#8220;NRS&#8221;) 78.411 through 78.444, inclusive) provide that specified types of business
      &#8220;combinations&#8221; between certain Nevada corporations and any person deemed to be an &#8220;interested stockholder&#8221; of the corporation are prohibited for two years after such person first becomes an &#8220;interested stockholder&#8221; unless the corporation&#8217;s board of
      directors approves the combination (or the transaction by which such person becomes an &#8220;interested stockholder&#8221;) in advance, or unless the combination is approved by the board of directors and sixty percent of the corporation&#8217;s voting power not
      beneficially owned by the interested stockholder, its affiliates and associates. Furthermore, in the absence of prior approval certain restrictions may apply even after such two-year period. For purposes of these statutes, an &#8220;interested stockholder&#8221;
      is any person who is (1) the beneficial owner, directly or indirectly, of 10% or more of the voting power of the outstanding voting shares of the corporation, or (2) an affiliate or associate of the corporation and at any time within the two previous
      years was the beneficial owner, directly or indirectly, of 10% or more of the voting power of the then-outstanding shares of the corporation. The definition of the term &#8220;combination&#8221; is sufficiently broad to cover most significant transactions
      between a corporation and an &#8220;interested stockholder&#8221;. These laws generally apply to Nevada corporations with 200 or more stockholders of record. However, a Nevada corporation may elect in its articles of incorporation not to be governed by these
      particular laws, but if such election is not made in the corporation&#8217;s original articles of incorporation, the amendment (1) must be approved by the affirmative vote of the holders of stock representing a majority of the outstanding voting power of
      the corporation not beneficially owned by interested stockholders or their affiliates and associates, and (2) is not effective until 18 months after the vote approving the amendment and does not apply to any combination with a person who first became
      an interested stockholder on or before the effective date of the amendment. We have not made such an election in our original articles of incorporation or in the Articles, and we have not amended the Articles to so elect.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;"><u>Control Shares Statutes</u></div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">In addition, the NRS contain provisions governing the acquisition of a controlling interest in certain Nevada corporations. Nevada&#8217;s &#8220;acquisition of controlling interest&#8221;
      statutes (NRS 78.378 through 78.3793, inclusive) govern the acquisition of a controlling interest in certain Nevada corporations. These &#8220;control share&#8221; laws provide generally that any person that acquires a &#8220;controlling interest&#8221; in certain Nevada
      corporations may be denied voting rights, unless a majority of the disinterested stockholders of the corporation elects to restore such voting rights. These laws will apply to us as of a particular date if we were to have 200 or more stockholders of
      record (at least 100 of whom have addresses in Nevada appearing on our stock ledger at all times during the 90 days immediately preceding that date) and do business in the State of </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="margin: 0px 0px 12pt; line-height: 11.4pt; text-indent: 0px;">Nevada directly or through an affiliated corporation, unless our articles of incorporation or bylaws in effect on the tenth day after the acquisition of a controlling interest
      provide otherwise. These laws provide that a person acquires a &#8220;controlling interest&#8221; whenever a person acquires shares of a subject corporation that, but for the application of these provisions of the NRS, would enable that person to exercise (1)
      one-fifth or more, but less than one-third, (2) one-third or more, but less than a majority or (3) a majority or more, of all of the voting power of the corporation in the election of directors. Once an acquirer crosses one of these thresholds,
      shares which it acquired in the transaction taking it over the threshold and within the 90 days immediately preceding the date when the acquiring person acquired or offered to acquire a controlling interest become &#8220;control shares&#8221; to which the voting
      restrictions described above apply. These laws may have a chilling effect on certain transactions if our Articles or Bylaws are not amended to provide that these provisions do not apply to us or to an acquisition of a controlling interest, or if our
      disinterested stockholders do not confer voting rights in the control shares.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-style: italic; font-weight: bold;">No Cumulative Voting</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The Articles do not provide for cumulative voting in the election of directors.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;<font style="font-weight: bold; font-style: italic;">Blank Check Preferred Stock</font></div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>We believe that the availability of the preferred stock under the Articles provides
      the Company with flexibility in addressing corporate issues that may arise. Having these authorized shares available for issuance will allow the Company to issue shares of preferred stock without the expense and delay of a special stockholders&#8217;
      meeting. The authorized shares of preferred stock, as well as shares of common stock, will be available for issuance without further action by the Company&#8217;s stockholders, with the exception of any actions required by applicable law or the rules&#160;of
      any stock exchange on which RCM&#8217;s securities may be listed. The board of directors will have the power, subject to applicable law, to issue classes or series of preferred stock that could, depending on the terms of the class or series, impede the
      completion of a merger, tender offer or other takeover attempt.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Action by Written Consent; Special Meetings of Stockholders; Advance Notice Procedure</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>The Articles provide that stockholders may take action by written consent if such
      consent is signed by the holders of record of the outstanding shares of the Company having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon
      were present and voted, and otherwise may only take action at duly called annual or special meetings.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The Bylaws provide that special meetings of stockholders may be called only by a majority of the members of our board or upon the written request of stockholders, in accordance
      with, and subject to, the provisions of the Bylaws, from stockholders who hold, in the aggregate, not less than twenty percent (20%) of the voting power of our outstanding shares.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">In addition, the Bylaws establish advance notice procedures for:</div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z8b1b5d356b8749b5983509e2b8c37fc4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; line-height: 11.4pt; margin-bottom: 12pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 11.4pt; margin-bottom: 12pt;">stockholders to nominate candidates for election as a director; and</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z301bc10d148a4d9e9d2562d79811c49b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; line-height: 11.4pt; margin-bottom: 12pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 11.4pt; margin-bottom: 12pt;">stockholders to propose topics for consideration at stockholders&#8217; meetings.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Stockholders must notify our corporate secretary in writing prior to the meeting at which the matters are to be acted upon or directors are to be elected. The notice must contain
      the information specified in the Bylaws. To be timely, the notice must be delivered to, or mailed and received at, the principal executive offices of the Company not less than ninety (90) days nor more than one hundred twenty (120) days prior to the
      one-year anniversary of the immediately preceding year&#8217;s annual meeting; provided, however, that in the event that no annual meeting was held in the previous year or the date of the annual meeting is called for a date that is more than thirty (30)
      days before or more than sixty (60) days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed and received, not later than the ninetieth (90th) day prior to such annual meeting or, if later, the tenth
      (10th) day following the day on which public disclosure of the date of such annual meeting was first made. In the case of a special meeting of stockholders called to elect directors, the stockholder notice must be delivered to, or mailed and received
      by, the Secretary of the Company at its principal executive offices not earlier than the one hundred twentieth (120th) day prior to such special meeting and not later than the ninetieth (90th) day prior to such special meeting or, if later, the tenth
      (10th) day following the day on which public disclosure (as defined in Section 3.13(h)) of the date of such special meeting was first made. These provisions may preclude some stockholders from bringing matters before the stockholders at an annual or
      special meeting or from nominating candidates for director at an annual or special meeting.&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;<font style="font-weight: bold; font-style: italic;">Removal of Directors.</font></div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Our board of directors is elected each year by our stockholders for a term expiring
      at the next annual meeting of stockholders. Our stockholders may remove directors with or without cause by the affirmative vote or written consent of the holders of two-thirds (2/3) of the combined voting power of all then issued and outstanding
      shares of stock of all classes and series of the Company entitled to vote generally for the election of directors, voting together as a single class. Our board of directors may appoint a director to fill a vacancy created by the expansion of the
      board of directors.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Transfer Agent And Registrar</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The transfer agent and registrar for our common stock is American Stock Transfer&#160;&amp; Trust Company, LLC whose address is 59 Maiden Lane, New York, New York 10005.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Nasdaq Capital Market Listing</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Our common stock is listed on The Nasdaq Capital Market under the symbol &#8220;RCMT.&#8221;</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">DESCRIPTION OF WARRANTS</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The following description, together with the additional information we may include in any applicable prospectus supplements and free writing prospectuses, summarizes the material
      terms and provisions of the warrants that we may offer under this prospectus, which may consist of warrants to purchase common stock or preferred stock and may be issued in one or more series. Warrants may be issued independently or together with
      common stock or preferred stock offered by any prospectus supplement, and may be attached to or separate from those securities. While the terms we have summarized below will apply generally to any warrants that we may offer under this prospectus, we
      will describe the particular terms of any series of warrants that we may offer in more detail in the applicable prospectus supplement and any applicable free writing prospectus. The terms of any warrants offered under a prospectus supplement may
      differ from the terms described below. However, no prospectus supplement will fundamentally change the terms that are set forth in this prospectus or offer a security that is not registered and described in this prospectus at the time of its
      effectiveness.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of
      warrant agreement, if any, including a form of warrant certificate, that describes the terms of the particular series of warrants we are offering. The following summaries of material provisions of the warrants and the warrant agreements are subject
      to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to the particular series of warrants that we may offer under this prospectus. We urge you to read the applicable
      prospectus supplements related to the particular series of warrants that we may offer under this prospectus, as well as any related free writing prospectuses, and the complete warrant agreements and warrant certificates that contain the terms of the
      warrants.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">General</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We will describe in the applicable prospectus supplement the terms relating to a series of warrants being offered, including:</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>the title of such securities;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>the offering price or prices and aggregate number of warrants offered;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>the currency or currencies for which the warrants may be purchased;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>if applicable, the date on and after which the warrants and the related securities will be separately transferable;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zc80dd6276664418ea2bf7d7831a36553" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="ze356ed0573d5475181fb1ee66e29a67b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which, and the currency in
              which, these shares may be purchased upon such exercise;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="za1f568ed0bcd4a4ba0a2483f22b9b6da" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and the warrants;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="ze3e4a09b32db46d3be6e02d3aacbe236" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the terms of any rights to redeem or call the warrants;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zeea54c5b4738457e9ef81de0b2fdf258" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the terms of any rights to force the exercise of the warrants;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z5cf7a38ad6dd4424ba3f130c0e7afc67" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z1942ca7ba39642238aa6fed73bb609b9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the dates on which the right to exercise the warrants will commence and expire;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z913da57dd79e41178ac4d53e635de6de" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the manner in which the warrant agreements and warrants may be modified;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="ze5a6198d95724498b46ab089d75b05a4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>a discussion of any material or special United States federal income tax consequences of holding or exercising the warrants;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z91c6850b1f4d447fa9da3e1cd7cf07e4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the terms of the securities issuable upon exercise of the warrants; and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="ze1ce9d917c33465d9677ad15b1eb25e7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>any other specific terms, preferences, rights or limitations of or restrictions on the warrants.</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including, in the case of
      warrants to purchase common stock or preferred stock, the right to receive dividends, if any, or, payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Exercise Of Warrants</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable
      prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus
      supplement. After the close of business on the expiration date, unexercised warrants will become void.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants by delivering the warrant certificate representing the
      warrants to be exercised together with specified information, and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement. We will set forth on the reverse side of the
      warrant certificate and in the applicable prospectus supplement the information that the holder of the warrant will be required to deliver to the warrant agent in connection with the exercise of the warrant.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Upon receipt of the required payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office
      indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant
      certificate for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise price for warrants.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Enforceability Of Rights By Holders Of Warrants</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Each warrant agent will act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder of
      any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including
      any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal
      action its right to exercise, and receive the securities purchasable upon exercise of, its warrants.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">DESCRIPTION OF RIGHTS</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The following is a general description of the terms of the rights we may issue from time to time unless we provide otherwise in the applicable prospectus supplement. Particular
      terms of any rights we offer will be described in the prospectus supplement relating to such rights.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">General</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We may issue rights to purchase common stock, preferred stock or units. Rights may be issued independently or together with other securities and may or may not be transferable by
      the person purchasing or receiving the rights. In connection with any rights offering to our stockholders, we may enter into a standby underwriting, backstop or other arrangement with one or more underwriters or other persons pursuant to which such
      underwriters or other persons would purchase any offered securities remaining unsubscribed for after such rights offering. In connection with a rights offering to our stockholders, we would distribute certificates evidencing the rights and a
      prospectus supplement to our stockholders on or about the record date that we set for receiving rights in such rights offering.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The applicable prospectus supplement will describe the following terms of any rights we may issue, including some or all of the following:</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>the title and aggregate number of the rights;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>the subscription price or a formula for the determination of the subscription price for the rights and the currency or currencies in which the subscription price may be payable;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>if applicable, the designation and terms of the securities with which the rights are issued and the number of rights issued with each such security or each principal amount of such security;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>the number or a formula for the determination of the number of the rights issued to each stockholder;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>the extent to which the rights are transferable;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>in the case of rights to purchase common stock or preferred stock, the type of stock and number of shares of stock purchasable upon exercise of one right;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>the date on which the right to exercise the rights will commence, and the date on which the rights will expire (subject to any extension);</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>if applicable, the minimum or maximum amount of the rights that may be exercised at any one time;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>the extent to which such rights include an over&#8209;subscription privilege with respect to unsubscribed securities;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>if applicable, the procedures for adjusting the subscription price and number of shares of common stock or preferred stock purchasable upon the exercise of each right upon the occurrence of certain events, including stock splits, reverse
                stock splits, combinations, subdivisions or reclassifications of common stock or preferred stock;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <br>
    <table cellspacing="0" cellpadding="0" id="z38609e4c87964d93bf2c99bff2a80e9f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the effect on the rights of any merger, consolidation, sale or other disposition of our business;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z41749e43fe3f4058a243815349b53a87" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the terms of any rights to redeem or call the rights;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z0ee272c13ea54e39be5d68841aa24571" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>information with respect to book&#8209;entry procedures, if any;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z15168951e1c44538b4ce71c3fbcd2073" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the terms of the securities issuable upon exercise of the rights;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z462cdc8b126f4662bf47aa612ef97827" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>if applicable, the material terms of any standby underwriting, backstop or other purchase arrangement that we may enter into in connection with the rights offering;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z3fbbf09ed4384fb090cfc87bf487c344" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>if applicable, a discussion of certain U.S. federal income tax considerations; and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="ze197d92a875e46e589ae4c20d6f4430a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>any other terms of the rights, including terms, procedures and limitations relating to the exchange and exercise of the rights.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Exercise of Rights</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Each right will entitle the holder to purchase for cash or other consideration such shares of stock or principal amount of securities at the subscription price as shall in each
      case be set forth in, or be determinable as set forth in, the prospectus supplement relating to the rights offered thereby. Rights may be exercised as set forth in the applicable prospectus supplement beginning on the date specified therein and
      continuing until the close of business on the expiration date set forth in the prospectus supplement relating to the rights offered thereby. After the close of business on the expiration date, unexercised rights will become void.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Upon receipt of payment and a subscription certificate properly completed and duly executed at the corporate trust office of the subscription agent or any other office indicated
      in the prospectus supplement, we will, as soon as practicable, forward the securities purchasable upon such exercise. If less than all of the rights represented by such subscription certificate are exercised, a new subscription certificate will be
      issued for the remaining rights. If we so indicate in the applicable prospectus supplement, holders of the rights may surrender securities as all or part of the exercise price for rights.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We may determine to offer any unsubscribed offered securities directly to stockholders, persons other than stockholders, to or through agents, underwriters or dealers or through
      a combination of such methods, including pursuant to standby underwriting, backstop or other arrangements, as set forth in the applicable prospectus supplement.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Prior to exercising their rights, holders of rights will not have any of the rights of holders of the securities purchasable upon subscription, including, in the case of rights
      to purchase common stock or preferred stock, the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up or to exercise any voting rights.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">DESCRIPTION OF UNITS</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We may issue units comprising one or more securities described in this prospectus in any combination. The following description sets forth certain general terms and provisions of
      the units that we may offer pursuant to this prospectus. The particular terms of the units and the extent, if any, to which the general terms and provisions may apply to the units so offered will be described in the applicable prospectus supplement.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Each unit will be issued so that the holder of the unit also is the holder of each security included in the unit. Thus, the unit will have the rights and obligations of a holder
      of each included security. Units will be issued pursuant to the terms of a unit agreement, which may provide that the securities included in the unit may not be held or transferred separately at any time or at any time before a specified date. A copy
      of the forms of the unit agreement and the unit certificate relating to any particular issue of units will be filed with the SEC each time we issue units, and you should read those documents for provisions that may be important to you. For more
      information on how you can obtain copies of the forms of the unit agreement and the related unit certificate, see &#8220;Where You Can Find More Information.&#8221;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The prospectus supplement relating to any particular issuance of units will describe the terms of those units, including, to the extent applicable, the following:</div>
    <table cellspacing="0" cellpadding="0" id="z68e3c4ef15d8474eb4efb486add4d10c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the designation and terms of the units and the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zed69a089bf9f491c8fb418b943510a77" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>any provision for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z8add92e62b3d48e998c5127c192bd6f8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>whether the units will be issued in fully registered or global form.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">PLAN OF DISTRIBUTION</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We may sell the securities covered hereby from time to time pursuant to underwritten public offerings, direct sales to the public, negotiated transactions, block trades or a
      combination of these methods. A distribution of the securities offered by this prospectus may also be effected through the issuance of derivative securities, including without limitation, warrants and subscriptions. We may sell the securities to or
      through underwriters or dealers, through agents, or directly to one or more purchasers. We may distribute securities from time to time in one or more transactions:</div>
    <table cellspacing="0" cellpadding="0" id="z20a026ef45c247f1abf19f7bbf780974" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>at a fixed price or prices, which may be changed;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zb8d60f595e8f4e7eb79a4e768e069e14" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>at market prices prevailing at the time of sale;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z1f9b676dcc9d4e2e859d34afc8011f05" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>at prices related to such prevailing market prices;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zb877eeb59b0747d395ca713923dd2656" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>at varying prices determined at the time of sale; or</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zd2bf7e1b8c374d15992428bd9c849476" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>at negotiated prices.</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We may also sell equity securities covered by this registration statement in an &#8220;at the market offering&#8221; as defined in Rule&#160;415 under the Securities Act. Such offering may be
      made into an existing trading market for such securities in transactions at other than a fixed price, either:</div>
    <table cellspacing="0" cellpadding="0" id="z20d2729b462f470d82172ca537283a06" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>on or through the facilities of The Nasdaq Capital Market or any other securities exchange or quotation or trading service on which such securities may be listed, quoted or traded at the time of sale; and/or</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zb26b8c2e5b2b4dd1b20f2ec5d673de9e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>to or through a market maker otherwise than on The Nasdaq Capital Market or such other securities exchanges or quotation or trading services.</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Such at&#8209;the&#8209;market offerings, if any, may be conducted by financial institutions acting as principal or agent.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">A prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you) will describe the terms of the offering of the
      securities, including, to the extent applicable:</div>
    <table cellspacing="0" cellpadding="0" id="z5bbc0585cf654de1a725c99c72dec935" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the name or names of any underwriters, dealers or agents participating in the offering, if any;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z97881c0ccdbb42edaba46d071890ec31" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the purchase price of the securities sold by us to any underwriter or dealer and the net proceeds we expect to receive from the offering;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z8d96ed468deb47be8234a127f0954cac" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>any option, under which underwriters may purchase additional securities from us;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z7eec75c5dd5d4aa4b676fcc7a288d542" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>any agency fees or underwriting discounts or commissions and other items constituting agents&#8217; or underwriters&#8217; compensation;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z0f30d1206fb04746a1ad83dccbd27c6e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>any public offering price;</div>
          </td>
        </tr>

    </table>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">11</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>any discounts or concessions allowed or reallowed or paid to dealers; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>any securities exchange or market on which the securities may be listed.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Only underwriters named in the prospectus supplement are underwriters of the securities offered by the prospectus supplement.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">If underwriters are used in the sale, they will acquire the securities for their own account and may resell the securities from time to time in one or more transactions at a
      fixed public offering price or at varying prices determined at the time of sale. The obligations of the underwriters to purchase the securities will be subject to the conditions set forth in the applicable underwriting agreement. We may offer the
      securities to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. Subject to certain conditions, the underwriters will be obligated to purchase all of the securities offered by the
      prospectus supplement, other than securities covered by any option to purchase additional securities. Any public offering price and any discounts, commissions or concessions allowed or reallowed or paid to dealers may change from time to time. We may
      use underwriters with whom we have a material relationship. We will describe in the prospectus supplement, naming the underwriter, the nature of any such relationship.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We may sell securities directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities, and we will describe any
      commissions and other compensation we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, our agent will act on a best&#8209;efforts basis for the period of its appointment.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We may authorize agents or underwriters to solicit offers by certain types of institutional investors to purchase securities from us at the public offering price set forth in the
      prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. We will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts
      in the prospectus supplement.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We may provide agents and underwriters with indemnification against civil liabilities related to this offering, including liabilities under the Securities Act, or contribution
      with respect to payments that the agents or underwriters may make with respect to these liabilities. Agents and underwriters may engage in transactions with, or perform services for, us in the ordinary course of business.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">All securities we may offer, other than common stock, will be new issues of securities with no established trading market. Any agents or underwriters may make a market in these
      securities, but will not be obligated to do so and may discontinue any market making at any time without notice. Accordingly, we cannot guarantee the liquidity of the trading markets for any securities.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Any underwriter may engage in overallotment, stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation&#160;M under the Exchange Act.
      Overallotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. Short covering
      transactions involve purchases of the securities in the open market after the distribution is completed to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold
      by the dealer are purchased in a stabilizing or covering transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the
      activities at any time. These transactions may be effected on any exchange or over&#8209;the&#8209;counter market or otherwise.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Any agents and underwriters who are qualified market makers on The Nasdaq Capital Market may engage in passive market making transactions in the securities on The Nasdaq Capital
      Market in accordance with Rule&#160;103 of Regulation&#160;M, during the business day prior to the pricing of the offering, before the commencement of offers or sales of the securities. Passive market makers must comply with applicable volume and price
      limitations and must be identified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security; if all independent bids are lowered below the passive
      market maker&#8217;s bid, however, the passive market maker&#8217;s bid must then be lowered when certain purchase limits are exceeded. Passive market making may stabilize the market price of the securities at a level above that which might otherwise prevail in
      the open market and, if commenced, may be discontinued at any time.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">12</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">LEGAL MATTERS</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Unless otherwise indicated in the applicable prospectus supplement, the validity of the shares of common stock and preferred stock offered by this prospectus, and any supplement
      thereto, as well as certain other matters of Nevada law in connection with such offering, will be passed upon for us by Brownstein Hyatt Farber Schreck, LLP, Las Vegas, Nevada. Certain other legal matters in connection with the offering, and the
      validity or enforceability of warrants or rights offered by this prospectus, and any supplement thereto,&#160; will be passed upon for us by Morgan, Lewis&#160;&amp; Bockius&#160;LLP. Additional legal matters may be passed upon for us or any underwriters, dealers
      or agents, by counsel that we will name in the applicable prospectus supplement.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">EXPERTS</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Macias, Gini &amp; O&#8217;Connell LLP, an independent registered public accounting firm, has audited the consolidated financial statements and financial statement schedule of RCM
      Technologies, Inc. and Subsidiaries for the year ended December 28, 2019 included in our Annual Report on Form 10-K for the year ended December 28, 2019, as set forth in their report, dated March 5, 2020, which is incorporated by reference in this
      prospectus and elsewhere in the registration statement. Such financial statements are incorporated by reference in reliance on Macias, Gini &amp; O&#8217;Connell LLP&#8217;s report, given on their authority as experts in accounting and auditing.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The consolidated balance sheet of RCM Technologies, Inc. and Subsidiaries as of December 29, 2018, and the related statements of income, comprehensive income, changes in
      stockholders' equity, and cash flows for the year ended December 29, 2018, and financial statement schedule for the year ended December 29, 2018, have been audited by EisnerAmper LLP, independent registered public accounting firm, as stated in their
      report which is incorporated by reference.&#160; Such financial statements and financial statement schedule have been incorporated by reference in reliance on the report of such firm given upon their authority as experts in accounting and auditing.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">WHERE YOU CAN FIND MORE INFORMATION</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC&#8217;s
      website at http://www.sec.gov.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We maintain a website at www.rcmt.com. Information contained in or accessible through our website does not constitute a part of this prospectus.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;"> <br>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">INFORMATION INCORPORATED BY REFERENCE</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The SEC allows us to &#8220;incorporate by reference&#8221; into this prospectus the information contained in documents that we file with them, which means that we can disclose important
      information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus. Information in this prospectus supersedes information incorporated by reference that we filed with the SEC
      before the date of this prospectus, while information that we file later with the SEC will automatically update and supersede prior information. Any information so updated and superseded shall not be deemed, except as so updated and superseded, to
      constitute a part of this prospectus. We incorporate by reference the documents listed below and any future filings we will make with the SEC under Sections&#160;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, prior to the
      termination of the offering. Notwithstanding the foregoing, unless specifically stated to the contrary, none of the information that is not deemed &#8220;filed&#8221; with the SEC, including information furnished under Items&#160;2.02 or 7.01 of any Current Report on
      Form&#160;8&#8209;K, will be incorporated by reference into, or otherwise included in, this prospectus:</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">13</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z83a800a352a6417a904d5313ae91ca8e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>our annual report on Form&#160;10&#8209;K for the fiscal year ended December&#160;28, 2019, as amended by Amendment No. 1 thereto;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z9e6209f32d214db199f3d76ed9bd2aa6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>our quarterly reports on Form&#160;10&#8209;Q for the quarters ended March&#160;28, 2020, June 27, 2020 and September 26, 2020;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zf6af5b82db0b4811999bab64869f3b63" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>our current reports on Form&#160;8&#8209;K filed with the SEC on January 17, 2020, April 23, 2020 (as amended on April 24, 2020), May 22, 2020, June 2, 2020, October 1, 2020, December 18, 2020 and January 15, 2021 (as to Items 5.02 and 9.01 only);
              and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zb36a8510435646bca25fdfea4a880879" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>the description of our common stock, par value $0.05 per share, contained in our Registration Statement on Form 10 filed with the SEC on March 1, 1982, to register such securities under the Securities Exchange Act of 1934, as amended,
              including any amendments filed for the purpose of updating such information.</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">We will provide, upon written or oral request, without charge to you, including any beneficial owner to whom this prospectus is delivered, a copy of any or all of the documents
      incorporated herein by reference other than the exhibits to those documents, unless the exhibits are specifically incorporated by reference into the information that this prospectus incorporates. You should direct a request for copies to us at
      Attention: Chief Financial Officer, 2500 McClellan Avenue, Suite 350, Pennsauken, NJ 08109 or you may call us at (856)&#160;356-4500.</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 14.4pt;">
      <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">DISCLOSURE OF COMMISSION'S POSITION ON INDEMNIFICATION </div>
      <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">FOR SECURITIES ACT LIABILITY</div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
    </div>
    <div style="line-height: 14.4pt;">
      <div style="line-height: 11.4pt; margin-bottom: 12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt">&#160;</font>Insofar as indemnification for liabilities arising under the Securities
        Act may be permitted to directors, officers or persons controlling the Company pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities
        Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in
        the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by
        controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">14</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="line-height: 14.4pt;">
      <div style="line-height: 11.4pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0859dc28d84a40c58a0576c6caa5aec5">

            <tr>
              <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: center; line-height: 14.8pt; margin-top: 80pt; margin-bottom: 12pt; font-size: 13pt; font-weight: bold;">$25,000,000</div>
    <div style="text-align: center; line-height: 22.8pt; margin-top: 12pt; margin-bottom: 20pt; font-size: 18pt; font-weight: bold;">RCM TECHNOLOGIES, INC.</div>
    <div style="text-align: center; line-height: 17.1pt; margin-top: 12pt; font-size: 14pt; font-weight: bold;">Common Stock</div>
    <div style="text-align: center; line-height: 17.1pt; font-size: 14pt; font-weight: bold;">Preferred Stock</div>
    <div style="text-align: center; line-height: 17.1pt; font-size: 14pt; font-weight: bold;">Warrants</div>
    <div style="text-align: center; line-height: 17.1pt; font-size: 14pt; font-weight: bold;">Rights to Purchase Common Stock, Preferred Stock or Units</div>
    <div style="text-align: center; line-height: 17.1pt; margin-bottom: 70pt; font-size: 14pt; font-weight: bold;">Units</div>
    <div style="text-align: justify; line-height: 11.4pt; margin-bottom: 12pt;">
      <table align="center" cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 40%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="z0859dc28d84a40c58a0576c6caa5aec5">

          <tr>
            <td style="width: 100%; vertical-align: top; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div>
                <div><font style="font-weight: bold;"> <br>
                  </font></div>
                <div><font style="font-weight: bold;">PROSPECTUS</font></div>
                <div><font style="font-weight: bold;"> <br>
                  </font></div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;"><br>
    </div>
    <div style="text-align: justify; line-height: 11.4pt;"><br>
    </div>
    <div style="line-height: 14.4pt;">
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
      <div style="line-height: 11.4pt; margin-top: 70pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0859dc28d84a40c58a0576c6caa5aec5">

            <tr>
              <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
        </div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%%%-->
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">PART II</div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">INFORMATION NOT REQUIRED IN PROSPECTUS</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Item&#160;14.&#160; Other Expenses of Issuance and Distribution</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The following table sets forth the estimated expenses in connection with the issuance and distribution of an amount of up to $25,000,000 of shares of our securities registered
      under this registration statement, other than any underwriting discounts and commissions. All amounts, except the SEC registration fee, are estimates.</div>
    <table align="center" cellspacing="0" cellpadding="0" border="0" id="zbb86c2fb543545eeaf6c91462e9ced56" style="border-collapse: collapse; width: 80%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

        <tr>
          <td style="width: 85.21%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">SEC registration fee</div>
          </td>
          <td style="width: 14.79%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">$2,728</div>
          </td>
        </tr>
        <tr>
          <td style="width: 85.21%; vertical-align: top;">
            <div style="line-height: 11.4pt;">Legal fees and expenses</div>
          </td>
          <td style="width: 14.79%; vertical-align: bottom; text-align: right;"> (1)</td>
        </tr>
        <tr>
          <td style="width: 85.21%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Accounting fees and expenses</div>
          </td>
          <td style="width: 14.79%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">(1)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 85.21%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Transfer agent and registrar fees and expenses</div>
          </td>
          <td style="width: 14.79%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">(1)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 85.21%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Stock exchange listing fees</div>
          </td>
          <td style="width: 14.79%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 11.4pt;">(1)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 85.21%; vertical-align: top;">&#160;</td>
          <td style="width: 14.79%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 85.21%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Printing, FINRA filing fee (if applicable) and miscellaneous expenses</div>
          </td>
          <td style="width: 14.79%; vertical-align: bottom; border-bottom: 4px double #000000;">
            <div style="line-height: 14.4pt;">
              <div style="text-align: right; line-height: 11.4pt;">(1)</div>
              <div style="line-height: 0pt;"><font style="line-height: 0pt;">&#160;</font></div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 85.21%; vertical-align: top;">
            <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Total</div>
          </td>
          <td style="width: 14.79%; vertical-align: bottom; border-bottom: 4px double #000000;">
            <div style="line-height: 14.4pt;">
              <div style="text-align: right; line-height: 11.4pt;">(1)</div>
              <div style="line-height: 0pt;"><font style="line-height: 0pt;">&#160;</font></div>
            </div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 64.099pt; line-height: 11.4pt;">
      <div><br>
      </div>
      <img width="246" height="1" src="image1.jpg"></div>
    <br>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;" class="DSPFListTable" id="zadff67d3c29b4638b0503d4610bdab05">

        <tr>
          <td style="width: 64.1pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(1)</td>
          <td style="width: auto; vertical-align: top;">
            <div>These fees will be dependent on the number and amount of securities offerings under this registration statement and, therefore, cannot be estimated at this time. In accordance with Rule&#160;430B, additional information regarding estimated fees
              and expenses will be provided at the time information as to an offering is included in a prospectus supplement.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">Item&#160;15.&#160; Indemnification of Directors and Officers</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Section 78.7502 of the Nevada Revised Statutes (&#8220;NRS&#8221;) permits a corporation to indemnify, pursuant to that statutory provision, a present or former director, officer, employee
      or agent of the corporation, or of another entity or enterprise for which such person is or was serving in such capacity at the request of the corporation, who was or is a party or is threatened to be made a party to any threatened, pending or
      completed action, suit or proceeding, except an action by or in the right of the corporation, against expenses, including attorneys&#8217; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred in connection therewith,
      arising by reason of such person&#8217;s service in such capacity if such person (i) is not liable pursuant to Section 78.138 of the NRS, or (ii) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best
      interests of the corporation and, with respect to a criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. In the case of actions brought by or in the right of the corporation, however, no indemnification
      pursuant to Section 78.7502 of the NRS may be made for any claim, issue or matter as to which such person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals therefrom, to be liable to the corporation or for
      amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the
      case, such person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Any discretionary indemnification pursuant to Section 78.7502 of the NRS, unless ordered by a court or advanced to a director or officer by the corporation in accordance with the
      Nevada Revised Statutes, may be made by a corporation only as authorized in each specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances. Such determination must be made (1)
      by the stockholders, (2) by the board of directors by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding, (3) if a majority vote of a quorum consisting of directors who were not parties to the
      action, suit or proceeding so orders, by independent legal counsel in a written opinion, or (4) if a quorum consisting of directors who were not parties to the action, suit or proceeding cannot be obtained, by independent legal counsel in a written
      opinion.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;">II-<font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">1</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Section 78.751 of the NRS further provides that indemnification pursuant to Section 78.7502 of the NRS does not exclude any other rights to which a person seeking indemnification
      or advancement of expenses may be entitled under our articles of incorporation, our bylaws. or any agreement, vote of stockholders or disinterested directors or otherwise, for either an action in the person&#8217;s official capacity or an action in another
      capacity while holding office, except that indemnification, unless ordered by a court pursuant to Section 78.7502 of the NRS or for the advancement of expenses, may not be made to or on behalf of any director or officer finally adjudged by a court of
      competent jurisdiction, after exhaustion of any appeals, to be liable for intentional misconduct, fraud or a knowing violation of law, and such misconduct, fraud or violation was material to the cause of action.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The Registrant&#8217;s Articles of Incorporation, as amended, provide that the Registrant shall, to the full extent permitted by the NRS, indemnify all persons whom it has the power to
      indemnify pursuant thereto, including officers and directors of the Registrant.&#160; The Registrant&#8217;s Amended and Restated Bylaws provide that provide that the Registrant shall, to the fullest extent permitted under the NRS, indemnify any and all persons
      whom it has the power to indemnify under said law from any and all expenses, liabilities or other matters referred to in such law.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The Registrant&#8217;s Amended and Restated Bylaws also provide that it shall pay the expenses of directors and officers incurred as a party to any threatened, pending or completed
      action, suit or proceeding, whether civil, criminal, administrative or investigative, as they are incurred and in advance of the final disposition of the action, suit or proceeding, but, if applicable law so requires, only upon receipt by the
      Registrant of an undertaking from the director or officer to repay the advanced amounts in the event it is ultimately determined by a final decision of a court of competent jurisdiction that the director or officer is not entitled to be indemnified
      by the Registrant.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Section 78.752 of the NRS empowers a corporation to purchase and maintain insurance or make other financial arrangements on behalf of an Indemnified Party for any liability
      asserted against such person and liabilities and expenses incurred by such person in his or her capacity as an Indemnified Party or arising out of such person&#8217;s status as an Indemnified Party whether or not the corporation has the authority to
      indemnify such person against such liability and expenses.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">The Registrant&#8217;s Articles of Incorporation, as amended, authorize the Registrant to maintain insurance to cover such liabilities. The Registrant has purchased Directors&#8217; and
      Officer&#8217;s Liability Insurance to protect directors and officers of the Registrant from any liability asserted against them for acts taken or omissions occurring in their capacities as such.&#160; The Registrant is not required to maintain such insurance
      and there can be no assurance that the Registrant will continue to maintain such insurance or coverage in such amounts.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;">II-<font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="line-height: 11.4pt; margin-bottom: 7pt; font-weight: bold;">Item&#160;16.&#160; Exhibits</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 7pt;">The following documents are filed as exhibits to this registration statement, including those exhibits incorporated herein by reference to one of our prior filings under the
      Securities Act or the Exchange Act as indicated in parentheses:</div>
    <table cellspacing="0" cellpadding="0" id="zcd948ddc07b941efba2c0081d0c8ccde" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 8.26%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div style="line-height: 14.4pt;">
              <div style="line-height: 0pt;"><font style="line-height: 0pt;">&#160;</font></div>
              <div style="text-align: center; line-height: 9.1pt; font-size: 8pt; font-weight: bold;">Exhibit<br>
                Number</div>
              <div style="line-height: 0pt;"><font style="line-height: 0pt;">&#160;</font></div>
            </div>
          </td>
          <td style="width: 91.74%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div style="line-height: 14.4pt;">
              <div style="line-height: 0pt;"><font style="line-height: 0pt;">&#160;</font></div>
              <div style="text-align: center; line-height: 9.1pt; font-size: 8pt; font-weight: bold;">Document</div>
              <div style="line-height: 0pt;"><font style="line-height: 0pt;">&#160;</font></div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 5px 0px 0px; text-align: right; text-indent: -10pt;">1.1*<br>
            </div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 5px 0px;">Form of Underwriting Agreement.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;">3.1<br>
            </div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Articles of Incorporation, as amended; incorporated by reference to Exhibit 3(a) to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended October 31, 1994, filed with the
              Securities and Exchange Commission on January 4, 1995.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;"><a href="https://www.sec.gov/Archives/edgar/data/700841/0000700841-96-000007-index.html">3.2</a></div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Certificate of Amendment of Articles of Incorporation; incorporated by reference to Exhibit A to the Registrant&#8217;s Proxy Statement, dated February 6, 1996, filed with the Securities and
              Exchange Commission on January 29, 1996.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;"><a href="https://www.sec.gov/Archives/edgar/data/700841/0000700841-96-000007-index.html">3.3</a></div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Certificate of Amendment of Articles of Incorporation; incorporated by reference to Exhibit B to the Registrant&#8217;s Proxy Statement, dated February 6, 1996, filed with the Securities and
              Exchange Commission on January 29, 1996.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;"><a href="https://www.sec.gov/Archives/edgar/data/700841/000110465914003656/a14-3986_1ex3d1.htm">3.4</a></div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Amended and Restated Bylaws; incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 23, 2014.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;"><a href="https://www.sec.gov/Archives/edgar/data/700841/000070084120000019/rightsplan052220.htm">4.1</a></div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 14.6pt; padding: 0px 0px 5px;">Rights Agreement, dated as of May 22, 2020, by and between the Registrant and American Stock Transfer &amp; Trust Company, LLC, as rights agent (incorporated by reference to Exhibit&#160;4.1 to
              the Registrant&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 22, 2020).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="text-align: right; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">4.2*</div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Form of Preferred Stock Certificate.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="text-align: right; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">4.3*</div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Form of Certificate of Designation of Preferred Stock.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="text-align: right; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">4.4*</div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Form of Warrant Agreement.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="text-align: right; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">4.5*</div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Form of Warrant Certificate.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="text-align: right; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">4.6*</div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Form of Rights Certificate.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="text-align: right; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">4.7*</div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Form of Unit Agreement.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="text-align: right; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">4.8*</div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Form of Unit Certificate.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;"><a href="exhibit51.htm">5.1</a></div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Opinion of Brownstein Hyatt Farber Schreck, LLP (filed herewith).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;"><a href="exhibit51.htm">23.1</a></div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="margin: 0px 0px 5px; line-height: 11.4pt;">Consent of Brownstein Hyatt Farber Schreck, LLP (included in its Opinion filed as Exhibit&#160;5.1 hereto).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;"><a href="exhibit232.htm">23.2</a></div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Consent of Macias, Gini &amp; O&#8217;Connell LLP (filed herewith).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;"><a href="exhibit233.htm">23.3</a></div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Consent of EisnerAmper LLP.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.26%; vertical-align: top;">
            <div style="margin: 0px 0px 0px 10pt; line-height: 11.4pt; padding: 0px 5px 0px 0px; text-align: right; text-indent: -10pt;"><a href="#POWEROFATTORNEY">24.1</a></div>
          </td>
          <td style="width: 91.74%; vertical-align: top;">
            <div style="line-height: 11.4pt; padding: 0px 0px 5px;">Powers of Attorney (included as part of the signature page hereof).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 11.4pt;"><img width="246" height="1" src="image1.jpg"></div>
    <table cellspacing="0" cellpadding="0" id="z8b2261acde3d48ddb8e5ac0a9b61aecb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 8pt;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">*</td>
          <td style="width: auto; vertical-align: top;">
            <div>To be filed by amendment or as an exhibit to a document filed under the Securities Exchange Act of 1934, as amended, and incorporated by reference herein.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 11.4pt; margin-bottom: 8pt;"><br style="line-height: 11.4pt;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;">II-<font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="line-height: 11.4pt; margin-bottom: 8pt; font-weight: bold;">Item&#160;17.&#160; Undertakings</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 8pt;">The undersigned registrant hereby undertakes:</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 11.4pt; margin-bottom: 8pt;">(1)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>To file, during any period in which offers
      or sales are being made, a post&#8209;effective amendment to this registration statement:</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 11.4pt; margin-bottom: 8pt;">(i)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>To include any prospectus required by
      Section&#160;10(a)(3) of the Securities Act;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 11.4pt; margin-bottom: 8pt;">(ii)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>To reflect in the prospectus any facts or
      events arising after the effective date of this registration statement (or the most recent post&#8209;effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
      statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high and of the
      estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than 20&#160;percent change in the maximum aggregate
      offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 11.4pt; margin-bottom: 8pt;">(iii)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>To include any material information with
      respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement;</div>
    <div style="line-height: 11.4pt; margin-bottom: 8pt;"><font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that paragraphs&#160;(1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to
      be included in a post&#8209;effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference in the
      registration statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of the registration statement.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 11.4pt; margin-bottom: 8pt;">(2)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>That, for the purpose of determining any
      liability under the Securities Act of 1933, each such post&#8209;effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the
      initial <font style="font-style: italic;">bona fide</font> offering thereof.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 11.4pt; margin-bottom: 8pt;">(3)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>To remove from registration by means of a
      post&#8209;effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 11.4pt; margin-bottom: 8pt;">(4)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>That, for the purpose of determining
      liability under the Securities Act of 1933 to any purchaser:</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 11.4pt; margin-bottom: 8pt;">(i)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Each prospectus filed by the registrant
      pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 11.4pt; margin-bottom: 8pt;">(ii)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Each prospectus required to be filed
      pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii), or (x)&#160;for the purpose of providing the information required by
      section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or date of the first sale of securities in the
      offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to
      the securities in the registration statement to which the prospectus relates, and the offering of such securities at that time shall be deemed to be the initial <font style="font-style: italic;">bona fide</font> offering thereof. <font style="font-style: italic;">Provided</font>, <font style="font-style: italic;">however</font>, that no statement made in a registration statement or prospectus that is part of this registration statement or made in a document incorporated or
      deemed incorporated by reference into this registration statement or prospectus that is a part of this registration statement will, as to a purchaser with a time of contract sale prior to such effective date, supersede or modify any statement that
      was made in this registration statement or prospectus that was a part of this registration statement or made in any such document immediately prior to such effective date.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;">II-<font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">(5)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>That, for the purpose of determining
      liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the
      underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be
      considered to offer or sell such securities to such purchaser:</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 11.4pt; margin-bottom: 12pt;">(i)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Any preliminary prospectus or prospectus of
      the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 11.4pt; margin-bottom: 12pt;">(ii)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Any free writing prospectus relating to
      the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 11.4pt; margin-bottom: 12pt;">(iii)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>The portion of any other free writing
      prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 11.4pt; margin-bottom: 12pt;">(iv)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Any other communication that is an offer
      in the offering made by the undersigned registrant to the purchaser.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">(6)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>That, for purposes of determining any
      liability under the Securities Act, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section&#160;15(d) of the
      Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the
      initial <font style="font-style: italic;">bona fide</font> offering thereof.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">(7)<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>If and when applicable, to file an
      application for the purpose of determining the eligibility of the trustee to act under subsection&#160;(a) of Section&#160;310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section&#160;305(b)(2) of the
      Act.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant
      pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
      unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of
      any action, suit or proceeding) is asserted against the registrant by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been
      settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such
      issue.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;">II-<font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;">SIGNATURES</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
      for filing on Form&#160;S&#8209;3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Pennsauken, State of New Jersey on January 15, 2021.</div>
    <table cellspacing="0" cellpadding="0" id="z412d8bb0132c4fb3a1e52e2110f461db" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 47.42%; vertical-align: top;">&#160;</td>
          <td style="width: 52.58%; vertical-align: top;" colspan="2">
            <div style="line-height: 11.4pt;">RCM TECHNOLOGIES,&#160;INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 47.42%; vertical-align: top;">&#160;</td>
          <td style="width: 52.58%; vertical-align: top;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 47.42%; vertical-align: top;">&#160;</td>
          <td style="width: 5.16%; vertical-align: top;">
            <div style="line-height: 11.4pt;">By:</div>
          </td>
          <td style="width: 47.42%; vertical-align: bottom;">
            <div style="line-height: 14.4pt;">
              <div style="text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"><u>&#160;/s/ Bradley S. Vizi</u></div>
            </div>
            <div style="line-height: 11.4pt;">Bradley S. Vizi<br>
              <font style="font-style: italic;">Executive Chairman and President</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 11.4pt; margin-top: 12pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter">
        <div style="text-align: center; line-height: 11.4pt;">II-<font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; font-weight: bold;"><a name="POWEROFATTORNEY"><!--Anchor--></a>POWER OF ATTORNEY</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Bradley S. Vizi and Kevin D. Miller, and each of them, as his true and
      lawful attorneys&#8209;in&#8209;fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post&#8209;effective amendments) to this registration
      statement and sign any registration statement for the same offering covered by the registration statement that is to be effective upon filing pursuant to Rule&#160;462 promulgated under the Securities Act of 1933, as amended, and to file the same, with
      all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys&#8209;in&#8209;fact and agents, and each of them, full power and authority to do and perform each and every act and thing
      requisite and necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys&#8209;in&#8209;fact and agents, or any of them, or
      their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates
      indicated.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3b65edf2fc6a4f3d823fa6a6938340ef">

          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Signature</u></div>
            </td>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Title</u></div>
            </td>
            <td style="width: 18.6%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Date</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 18.6%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 14.4pt;">
                <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"><u>/s/ Bradley S. Vizi</u></div>
              </div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Bradley S. Vizi</div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 11.4pt;">Executive Chairman, President and Director (Principal Executive Officer)</div>
              <div style="line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 18.6%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 11.4pt;">January 15, 2021</div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 18.6%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 14.4pt;">
                <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"><u>/s/ Kevin D. Miller</u></div>
              </div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Kevin D. Miller</div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 11.4pt;">Chief Financial Officer, Treasurer and Secretary (Principal Financial and Accounting Officer)</div>
              <div style="line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 18.6%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 11.4pt;">January 15, 2021</div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 18.6%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 14.4pt;">
                <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"><u>/s/ Roger H. Ballou</u></div>
              </div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Roger H. Ballou</div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 11.4pt;">Director</div>
              <div style="line-height: 11.4pt;"> <br>
              </div>
              <div style="line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 18.6%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 11.4pt;">January 15, 2021</div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 18.6%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 14.4pt;">
                <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"><u>/s/ Richard A. Genovese</u></div>
              </div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Richard A. Genovese</div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 11.4pt;">Director</div>
              <div style="line-height: 11.4pt;"> <br>
              </div>
              <div style="line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 18.6%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 11.4pt;">January 15, 2021</div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 18.6%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 14.4pt;">
                <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"><u>/s/ Swarna Srinivas Kakodkar</u></div>
              </div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Swarna Srinivas Kakodkar</div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 11.4pt;">Director</div>
              <div style="line-height: 11.4pt;"> <br>
              </div>
              <div style="line-height: 11.4pt;"> <br>
              </div>
            </td>
            <td style="width: 18.6%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 11.4pt;">January 15, 2021</div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
              <div style="text-align: center; line-height: 11.4pt;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 40.7%; vertical-align: bottom;">&#160;</td>
            <td style="width: 18.6%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 14.4pt;">
                <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;"><u>/s/ Jayanth S. Komarneni</u></div>
              </div>
              <div style="text-align: center; text-indent: -10pt; margin-left: 10pt; line-height: 11.4pt;">Jayanth S. Komarneni</div>
            </td>
            <td style="width: 40.7%; vertical-align: bottom;">
              <div style="line-height: 11.4pt;">Director</div>
            </td>
            <td style="width: 18.6%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 11.4pt;">January 15, 2021</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div>
    <div style="line-height: 11.4pt; margin-top: 12pt; margin-bottom: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div id="DSPFPageFooter">
      <div style="text-align: center; line-height: 11.4pt;">II-<font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit51.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: RCM Technologies, Inc.
         Document created using EDGARfilings PROfile 7.2.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader"><br>
      <div style="line-height: 11.4pt;"><a name="z_mps019661780000000000000006995000000000"></a>&#160;</div>
    </div>
    <div style="line-height: 0pt;"><br style="line-height: 0pt;">
    </div>
    <div style="line-height: 11.4pt; margin-top: 12pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt; margin-top: 12pt; font-family: Arial;">January 15, 2021</div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt; font-family: Arial;">R C M Technologies, Inc.</div>
    <div style="line-height: 11.4pt; font-family: Arial;">2500 McClellan Avenue, Suite 350</div>
    <div style="line-height: 11.4pt; font-family: Arial;">Pennsauken, NJ 08109-4613</div>
    <div style="line-height: 11.4pt; font-family: Arial;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">Ladies and Gentlemen:</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">We have acted as local Nevada counsel to R C M Technologies, Inc., a Nevada corporation (the &#8220;<u>Company</u>&#8221;), in
      connection with the filing by the Company of a Registration Statement on Form S-3 (the &#8220;<u>Registration Statement</u>&#8221;) with the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<u>Act</u>&#8221;),
      relating to the registration for offering and sale from time to time by the Company of an indeterminate number of the following securities of the Company, with an aggregate initial offering price of up to $25,000,000, pursuant to the prospectus
      included therein (the &#8220;<u>Prospectus</u>&#8221;): (i) shares (the &#8220;<u>Common Shares</u>&#8221;) of the Company&#8217;s common stock, par value $0.05 per share (the &#8220;<u>Common Stock</u>&#8221;), which Common Shares include any shares of Common Stock issuable upon the (x)
      conversion or exchange, as applicable, of any Preferred Shares (as defined below)&#160; and (y) exercise of any Warrants (as defined below) to purchase shares of Common Stock, (ii) shares (the &#8220;<u>Preferred Shares</u>&#8221; and, together with the Common
      Shares, the &#8220;<u>Shares</u>&#8221;) of the Company&#8217;s preferred stock, par value $1.00 per share (the &#8220;<u>Preferred Stock</u>&#8221;) in one or more classes or series, which Preferred Shares include any shares of Preferred Stock issuable upon the exercise of any
      Warrants to purchase shares of Preferred Stock; (iii) warrants to purchase shares of Common Stock or shares of Preferred Stock (the &#8220;<u>Warrants</u>&#8221;) to be issued pursuant to one or more warrant agreements (each, a &#8220;<u>Warrant Agreement</u>&#8221;); (iv)
      rights (the &#8220;<u>Rights</u>&#8221;) to purchase Common Stock, Preferred Stock or Units (as defined below) to be issued pursuant to one or more standby underwriting, backstop or other agreements with one or more underwriters or other persons (each, a &#8220;<u>Rights
        Agreement</u>&#8221;); and (v) units comprising shares of Common Stock, shares of Preferred Stock and/or Warrants (the &#8220;<u>Units</u>&#8221; and, together with the Shares, the Warrants and the Rights, the &#8220;<u>Securities</u>&#8221;) to be issued pursuant to one or
      more unit agreements (each, a &#8220;<u>Unit Agreement</u>&#8221;).&#160; This opinion letter is being furnished at your request in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Act.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">In our capacity as such counsel, we are familiar with the proceedings taken and proposed to be taken by the Company in
      connection with the registration of the Securities as described in the Registration Statement.&#160; For purposes of this opinion letter, and except to the extent set forth in the opinions expressed below, we have assumed that all such proceedings have
      been or will be timely completed in the manner presently proposed in the Registration Statement and the Prospectus.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">For purposes of issuing this opinion letter, we have made such legal and factual examinations and inquiries, including an
      examination of originals or copies certified or otherwise identified to our satisfaction as being true copies of (i) the Registration Statement including the Prospectus, (ii) the articles of incorporation and bylaws of the Company, each as amended to
      date (collectively, the &#8220;<u>Governing Documents</u>&#8221;), and (iii) such other agreements, instruments, corporate records and other documents as we have deemed necessary or appropriate for the purpose of issuing this opinion letter, and we have obtained
      from officers and other representatives and agents of the Company and from public officials, and have relied upon, such certificates, representations and assurances, and public filings, as we have deemed necessary or appropriate.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">
      <div style="text-align: right; line-height: 9.1pt; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><a name="z_mps403437800000000000000006995000000000"></a><font style="font-family: Arial;">100 North City Parkway, Suite 1600<br>
          Las Vegas, NV&#160; 89106</font></div>
      <div style="text-align: right; line-height: 9.1pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><font style="font-family: Arial;">main</font><font style="font-family: Arial;">
          702.382.2101</font></div>
      <div style="text-align: right; line-height: 9.1pt; font-size: 8pt;">Brownstein Hyatt Farber Schreck, LLP</div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageFooter">
        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
        </div>
      </div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div id="DSPFPageHeader"><br>
        <div style="line-height: 11.4pt;"><a name="z_mps019661780000000000000006995000000000"></a>&#160;</div>
      </div>
    </div>
    <div style="margin: 0px; line-height: 11.4pt; font-family: Arial; text-indent: 0px;"> R C M Technologies, Inc.<br>
    </div>
    <div style="margin: 0px; line-height: 11.4pt; font-family: Arial; text-indent: 0px;">January 15,2021</div>
    <div style="margin: 0px 0px 12pt; line-height: 11.4pt; font-family: Arial; text-indent: 0px;">Page 2<br>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">Without limiting the generality of the foregoing, in our examination and in issuing this opinion letter, we have, with your
      permission, assumed without independent verification, that (i) each document we have reviewed or which is referenced herein has been or will be duly executed and delivered by the parties thereto to the extent due execution and delivery are
      prerequisites to the effectiveness thereof; (ii) any and all agreements, instruments or other documents relating to the offering, issuance or sale of any Securities, including, without limitation, any and all Warrant Agreements (including each
      warrant certificate contemplated thereby), Rights Agreements (including each certificate evidencing the Rights) and Unit Agreements (including each unit certificate contemplated thereby) (collectively, the &#8220;<u>Securities Documents</u>&#8221;) have been or
      will be duly authorized, executed and delivered by the Company; (iii) the obligations of each party set forth in the Securities Documents are or will be its valid and binding obligations, enforceable in accordance with their respective terms; (iv) no
      Securities have been or will be offered, issued or sold in violation or breach of, nor will any such offering, issuance or sale result in a default under, the Governing Documents, any agreement or instrument that is binding upon the Company or any
      requirement or restriction imposed by any governmental or regulatory agency, authority or body; (v) the Company has taken or will take all corporate action required in connection with the authorization, offering, issuance and sale of Securities
      (including, without limitation, any Shares or other securities of the Company underlying any Preferred Shares, Warrants, Rights or Units), and all Securities have been or will be offered, issued and sold, in compliance with all applicable laws, the
      Governing Documents and the relevant Securities Documents in effect at all relevant times, and any and all certificates evidencing Shares, Warrants, Rights or Units are or will be properly signed, registered and delivered, as necessary, in accordance
      with all applicable laws, the Governing Documents and the relevant Securities Documents (collectively, &#8220;<u>Corporate Proceedings</u>&#8221;); (vi) after any issuance of Common Shares, the total number of issued and outstanding shares of Common Stock,
      together with the total number of shares of Common Stock then reserved for issuance or obligated to be issued by the Company pursuant to any agreement or arrangement or otherwise (including, without limitation, pursuant to the terms of any
      Securities), will not exceed the total number of shares of Common Stock then authorized under the Company&#8217;s articles of incorporation; (vii) the voting rights, designations, preferences, limitations, restrictions, privileges and relative rights of
      each class or series of Preferred Shares have been or will be fixed in a certificate of designation relating to such class or series, prepared in the form prescribed by applicable law, duly signed by an officer of the Company and properly filed with
      the Nevada Secretary of State (each, a &#8220;<u>Certificate of Designation</u>&#8221;) prior to the issuance of any shares of such class or series of Preferred Shares, and at no time will the total number of shares of Preferred Stock designated pursuant to all
      then-effective Certificates of Designation exceed the total number of shares of Preferred Stock then authorized under the Company&#8217;s articles of incorporation; (viii) after any issuance of Preferred Shares, the total number of issued and outstanding
      shares of each class or series thereof, together with the total number of shares of such class or series then reserved for issuance or obligated to be issued by the Company pursuant to any agreement or arrangement or otherwise (including, without
      limitation, pursuant to the terms of any Securities), will not exceed the total number of shares of such class or series then designated under the Certificate of Designation for such class or series; (ix) the statements of fact and representations
      and warranties set forth in the documents we have reviewed are, or at all relevant times will be, true and correct as to factual matters; (x) each natural person executing a document has or will have sufficient legal capacity to do so; (xi) all
      documents submitted to us as originals are authentic, the signatures on all documents that we have reviewed are genuine, and all documents submitted to us as certified, conformed, photostatic, electronic or facsimile copies conform to the original
      documents; and (xii) all corporate records made available to us by the Company, and all public records we have reviewed, are accurate and complete.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">We are qualified to practice law in the State of Nevada.&#160; The opinions set forth herein are expressly limited to and based
      exclusively on the general corporate laws of the State of Nevada, and we do not purport to be experts on, or to express any opinion with respect to the applicability thereto or the effect thereon of, the laws of any other jurisdiction.&#160; We express no
      opinion concerning, and we assume no responsibility as to laws or judicial decisions related to, or any orders, consents or other authorizations or approvals as may be required by, any federal laws, rules or regulations, including, without
      limitation, any federal securities laws, rules or regulations, or any state securities or &#8220;blue sky&#8221; laws, rules or regulations.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageFooter">
        <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
        </div>
      </div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div id="DSPFPageHeader"><br>
        <div style="line-height: 11.4pt;"><a name="z_mps019661780000000000000006995000000000"></a>&#160;</div>
      </div>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">
      <div style="margin: 0px; line-height: 11.4pt; text-indent: 0px;"> R C M Technologies, Inc.<br>
      </div>
      <div style="margin: 0px; line-height: 11.4pt; text-indent: 0px;">January 15,2021</div>
      <div style="margin: 0px 0px 12pt; line-height: 11.4pt; text-indent: 0px;">Page 3<br>
      </div>
    </div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">Based upon the foregoing and in reliance thereon, and having regard to legal considerations and other information that we
      deem relevant, we are of the opinion that:</div>
    <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: Arial;">1.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: Arial;">&#160;</font><font style="font-family: Arial;">If and when all Corporate Proceedings have been taken and completed in respect of any offering, issuance or sale of Shares, and to the extent such Shares have been issued in accordance with all
        applicable terms and conditions set forth in the relevant Securities Documents and any relevant Certificates of Designation, including proper conversion, exchange or exercise of any relevant Securities, and payment in full of all consideration
        required therefor as authorized by such Corporate Proceedings and prescribed by such Securities Documents, Certificates of Designation and other Securities, as applicable, such Shares will be duly authorized, validly issued, fully paid and
        non-assessable.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: Arial;">2.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: Arial;">&#160;</font><font style="font-family: Arial;">If and when all Corporate Proceedings have been taken and completed in respect of any offering, issuance or sale of Warrants, Rights or Units, such Securities will be duly authorized.</font></div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">The opinions expressed herein are based upon the applicable laws of the State of Nevada and the facts in existence on the
      date hereof.&#160; In delivering this opinion letter to you, we disclaim any obligation to update or supplement the opinions set forth herein or to apprise you of any changes in any laws or facts after such time as the Registration Statement is declared
      effective.&#160; No opinion is offered or implied as to any matter, and no inference may be drawn, beyond the strict scope of the specific issues expressly addressed by the opinions set forth herein.</div>
    <div style="text-indent: 36pt; line-height: 11.4pt; margin-bottom: 12pt; font-family: Arial;">We hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the reference to
      our firm therein under the heading &#8220;Legal Matters&#8221;.&#160; In giving such consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission promulgated
      thereunder.</div>
    <div style="line-height: 11.4pt; font-family: Arial;">Very truly yours,</div>
    <div style="line-height: 11.4pt; font-family: Arial;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt; font-family: Arial;">/s/ Brownstein Hyatt Farber Schreck, LLP</div>
    <div style="line-height: 11.4pt; font-family: Arial;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt; font-family: Arial;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt; font-family: Arial;"><br style="line-height: 11.4pt;">
    </div>
    <div id="DSPFPageFooter">
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>exhibit232.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: RCM Technologies, Inc.
         Document created using EDGARfilings PROfile 7.2.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
      </div>
    </div>
    <div style="text-align: right; line-height: 11.4pt;">Exhibit 23.2</div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: center; line-height: 13pt; margin-bottom: 13pt;"><u>Consent of Independent Registered Public Accounting Firm</u></div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: justify; line-height: 11.4pt;">We consent to the incorporation by reference in this Registration Statement on Form S-3 and the related Prospectus of RCM
      Technologies, Inc. and Subsidiaries of our report dated March 5, 2020, relating to our audit of the consolidated financial statements and financial statement schedule included in the Annual Report on Form 10-K of RCM Technologies, Inc. and
      Subsidiaries for the year ended December 28, 2019.</div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: justify; line-height: 11.4pt;">We also consent to the reference to us under the caption &#8220;Experts&#8221; in the Prospectus constituting a part of this Registration
      Statement.</div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt;">/s/ Macias, Gini &amp; O&#8217;Connell LLP</div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt;">Macias, Gini &amp; O&#8217;Connell LLP</div>
    <div style="line-height: 11.4pt;">San Diego, California</div>
    <div style="line-height: 11.4pt;">January 15, 2021</div>
    <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
    </div>
    <div id="DSPFPageFooter">
      <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>4
<FILENAME>exhibit233.htm
<DESCRIPTION>EXHIBIT 23.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: RCM Technologies, Inc.
         Document created using EDGARfilings PROfile 7.2.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="line-height: 13.7pt;"><br style="line-height: 13.7pt;">
      </div>
    </div>
    <div style="text-align: justify; line-height: 12.55pt; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: justify; line-height: 11.4pt;">We consent to the incorporation by reference in this Registration Statement of RCM Technologies, Inc. and Subsidiaries on Form S-3 to
      be filed on or about January 15, 2021 of our report dated March 11, 2019, on our audit of the consolidated financial statements and financial statement schedule as of December 29, 2018 and for the year then ended, which report was included in the
      Annual Report on Form 10-K filed on March 5, 2020.&#160; We also consent to the reference to our firm under the caption &#8220;Experts&#8221; in this Registration Statement.</div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt;">/s/ EISNERAMPER LLP<br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
    </div>
    <div style="text-align: justify; line-height: 11.4pt;">EISNERAMPER LLP</div>
    <div style="text-align: justify; line-height: 11.4pt;">Iselin, New Jersey</div>
    <div style="text-align: justify; line-height: 11.4pt;">January 15, 2021</div>
    <div id="DSPFPageFooter">
      <div style="line-height: 10pt;"><br style="line-height: 10pt;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /Y!/X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \W^(@;1_$FA>(X^#$_ER$=P#G'XJSBO1HY%EB21#E74,I]0:Y
M;XBZ?]O\&W;A<R6I6X7Z*?F_\=+4?#O53J?A*WCD;,UF?L[_ $7[I_[YQ^5=
M4UST(R[:&2TFUW.KHHHKE-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %07MLE[87%JXRDT;1GZ$8
MJ>BA.VH'@'A6_;1O%.G32G8J3^1-GL&^0Y^AY_"O?Z\"\96'V/Q9JUN%^5YC
M*O\ P,;_ .9/Y5[5X>O_ .T_#MA>9RTL*EC_ +6,']<UZ..7,HU%U.>@[-Q-
M.BBBO..@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH \B^*EIY/B*UN0.+BVQQW*-S^C"NA^%=^9] NK%CS:3G;_N/\P_7=3/BO
M9^9HEE>@<V]QL8^BN/\ $+7.?#"_^S>*9+4L=MW 5 ]63YA^FZO3M[3">GZ?
M\ YOAJGL5%%%>8=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!SWCBU^U^#-30=8XO-'ML(;^E>,:)?'3=>T^]# "&X0L?]DG#
M?^.DU]!W,"75K-;R#*2H48>H(P:^:S$Z*T,@Q(F4?V(X/ZUZF ?-"4'_ %<Y
MJ^DDSZ9HK+\-W_\ :?AK3KS.6D@7?_O 8;]0:U*\R2<6TSH3NKA1112&%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\_\ BJU^Q>+-
M5AV8'VEI%'L_S?UKZ KQ?XF6WD>,VDYQ<6T<F??YE/Z*/SKNP$K5&O(PKKW;
MG7_"R\\[PU-9D\VMPP ]%?YOYEJ[FO)/A5>^5KU[9DX%Q;B1<^J''\F_2O6Z
MRQ<>6L_,ND[P04445S&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7F7Q:M@#I-X.#^\A8^N0&'\F_.O3:XKXHVYE\*+,!S!<HQ/H#
ME?ZBNC"RM6B9U5>#/.?!UY]A\8Z7-GY6F\IOHZE?YD'\*][KYJ65[=UGC/SQ
M,)%QZJ<_TKZ1MYTN;:*XB8-'*@=2.X(R*Z<PC[T9&>'>C1)1117G'0%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@>-K;[5X+U9/[E
MN91[[/G_ /9:WZANX%NK*>W<966-D8>H(Q50ERR4NPI*ZL?-V,]N*]U\"77V
MKP5I9.,Q1>21_N$J/T KPE5**%8'<O!^O>O6?A1=B30KVT_B@N=V/9@,?J#7
MK8Z-Z5^QR4'[QW]%%%>.=@4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!\ZZQ +77-1M\G$=S(G_CQKL/A3=>7KU_:Y^6>V$G/J
MC8_]G/Y5A>.(1;^-M511M5I$<>^Z-23^>:=X%NC:^--..[B5FB/_  )3_4"O
M<J+GP_R_X)PQ]VH>ZT445X9W!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\^'_ )ZI_P!]"CSX?^>J?]]"OAS_ (2O7O\ H*W7_?PT?\)7KW_05NO^_AH
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M#7/^?Z3\Z^E?@1?W6H_#U[B[E,LGVZ4 GTPM?)M?5/[/?_)-'_Z_Y?\ T%*
M/5J*** "BBB@ HHHH *^?/$L7D>*]70G_E\D?_OIBW]:^@Z\*\=Q>3XXU0<8
M=XW'XQKG]<UWY>_?:\C#$+W4<V_W#SDXKZ0T^?[3IMK/G/FPH_Y@&OG$C(QD
M<C%>_>$I_M'A'292<DVJ _4#!_E6N8+W8LC#O5HV:***\LZ@HHHH X+XT?\
M))M;_P!V+_T:E?'M?9'Q=L[F_P#AAK%K9P///((@L:#)/[U/Z5\K?\(1XF_Z
M MW_ -\4 8%%;_\ PA'B;_H"W?\ WQ1_PA'B;_H"W?\ WQ0!@45=U+2-0T>5
M(]0M);9W7<JR#&15>VMIKRYCMK>-I)I6"HBCECZ4 145O_\ "$>)O^@+=_\
M?%'_  A'B;_H"W?_ 'Q0!@5[Q^S1_P ?_B/_ *Y0?S>O)O\ A"/$W_0%N_\
MOBO:?V>M#U31K[7CJ-C-;"6*'89%QNP7S_.@#W>BBB@ HHHH **** "BBB@
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M->>?#?CXD^&_>_B_]"KT+]I+_D;-'_Z\3_Z&:\\^&_\ R4KPY_V$(O\ T(4
M?:VT>@_*C:/0?E2T4 )M'H/RH  Z"EHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KC/BS_R2SQ!_U[#_ -"6NSKC/BS_ ,DL\0?]>P_]"6@#
MXSK[OT+_ )%[3,_\^D7_ * *^$*^[]"Y\/:8?^G2+_T 4 :%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5\@_&W_DK.L?2'_P!%)7U]7R#\;?\ DK.L?2'_ -%)0!W/[,__ !]^)/\
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M.J*ZMHKRTFM9UW0S(T;KZJ1@T ? M%7=8TY](UJ^TV0Y>TN'@8^I5B/Z52H
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MB@ KR7XKKC7[!_[UJ1^3'_&O6J\N^+48^V:3)C[R2J3]"O\ C75@G^^1E6^
M\Y_$UZ?\)),VNJPYX62-@/J"/Z"O,,GN:]"^$LN-2U2'/!AC8?@2/ZUZ6+5Z
M,CGI?&CU6BBBO#.T**** "BBB@ HHHH ^:_VDO\ D:]'_P"O$_\ H9KSSX;_
M /)2O#G_ &$(O_0A7H?[27_(UZ/_ ->)_P#0S7GGPW_Y*5X<_P"PA%_Z$* /
MM>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC/BS
M_P DL\0?]>P_]"6NSKC/BS_R2SQ!_P!>P_\ 0EH ^,Z^[]".?#VF'_ITB_\
M0!7PA7W?H7/A[33_ -.D7_H H T**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY!^-O_)6=8^D/_HI*
M^OJ^0?C;_P E9UCZ0_\ HI* .Y_9G/\ I?B0?],[?^<E?0M?/7[,_P#Q]^)/
M]RW_ )R5]"T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA"ON_0N/#VF@?\^D7_H H T**** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 9^@?'+6[;7;5/$-HL6GSEBQ5<'D<8]LD5]#0RQSPQS1.'CD4,C \$'D&N
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MWAFR;^[?*?\ R'(/ZUT87^-$SJ_ SR/CT-=!X&8)XYTACD?O)!^<3C^M<_\
MB:U?#$AC\5Z0P)_X^XQ^9Q_6O9J*\)+R9QQ^)'T%1117SQZ 4444 %%%% !1
M110!\U_M)?\ (UZ/_P!>)_\ 0S7GGPW_ .2E>'/^PA%_Z$*]#_:2_P"1KT?_
M *\3_P"AFO//AO\ \E*\.?\ 80B_]"% 'VO1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5QGQ9_Y)9X@_Z]A_Z$M=G7&?%G_DEGB#
M_KV'_H2T ?&=?=^A#'A[3!_TZ1?^@"OA"ON_0N/#VF?]>D7_ * * -"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *^0?C;_ ,E9UCZ0_P#HI*^OJ^0?C;_R5G6/I#_Z*2@#N?V9_P#C
M[\2'_IG;_P Y*^A:^>OV9_\ C[\2?]<[?^<E?0M !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?]G^(],O-Q7R+N*4D=L.#0!]W4444 %%%% $%]=)8Z?<WDG^K@B:5OHH)/\
M*O@AF+NS,<ECDFOMCXB70L_AQXCF)Q_Q+YD!]V4J/U(KXFH ]O\ V=K)6G\3
MW[+\T5HD*M[-N)_] %>(5]'?L]6FSP/X@O"!B:X\K_OB,'_V>OG&@ KZI_9Z
M_P"2:/\ ]?\ +_Z"E?*U?5/[/7_)-'_Z_P"7_P!!2@#U:BBB@ HHHH ****
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M=YJ5I8!#<SK'O.%R>M,M=7L;V4Q6]PDCCD@&OBB^\7:[J$I>XU.X<;BR@O\
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MOFWN>D%%%%( HHHH **** /FO]I+_D:]'_Z\3_Z&:\\^&_\ R4KPY_V$(O\
MT(5Z'^TE_P C7H__ %XG_P!#->>?#?\ Y*5X<_["$7_H0H ^UZ*** "BBB@
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M_% $-QH&F76F-I\MK&ULR>64Q_#7RM\7O __  AOBD-;+C3[[=+!@<*0>4_
M%?SKZ\KRKX_Z-_:/PZ-\@'F:=<I,3WV-\A'YLI_"@#Y9@FDM[B.>)MLD;!U(
M[$'(K[RTZ]BU/3+2_@.Z&ZA2:,^JLH(_0U\$U]I_#&\^W?#+P[+_ ';)(O\
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M;%95>1V_Y9@\9_*OIW3K"WTO3K>QM4"06\8C11V J2*V@@)\J)$R,':,5+0
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M?^<E 'T-1110 4444 %%%% !1110 5XG^TG_ ,BMHW_7ZW_H!KVRO$_VD_\
MD5M&_P"OUO\ T T ?-E?9_PK_P"27^'O^O0?S-?&%?9_PK_Y)?X>_P"O0?S-
M 'S[\>[ V?Q2N9NUY;0SC\%\O_VG7F5>V_M)V)C\3Z+J':>S:'_OAR?_ &I7
MB5 'N/[->H"+7M=TW'-Q:QW /_7-BO\ [5KZ.KY1^ %\;3XGQ0_\_=I-"?P
MD_\ 9*^KJ "BBB@#X^^--U]J^+&L^D1BB'X1K_7-4OA38_VC\4O#T!_ANO/_
M ._:F3_V6J'CVZ-[\0?$4^[<&U&<*WJH<@?H!77_   L1=_$^*<_\N=I-,/Q
M C_]GH ^I[W_ (\;C'_/)OY5\#U]\7O_ !XW'_7)OY5\#T %?5'[/6?^%:O_
M -?\O_H*5\KU]4?L]?\ )-7]K^7_ -!2@#U>BBB@ HHHH **** "N.^)I/\
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M^0?C;_R5G6/I#_Z*2@#N?V9_^/OQ)_N6_P#.2OH6OGK]F?\ X^_$A_Z9V_\
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MA7V77PIX;O1IOBG1[\C(M;V&8_\  7!_I7W70!\:?%N[^V_%7Q!*/X;@1?\
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M_P"1*TG_ *]Q6_7.> R3X(TO)SB,C\F(KHZ^>K?Q)>K/0A\*"BBBLR@HHHH
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MXBVS#JVG1Y_[[>O._"4YM?&>A7 QF+4+=^?:137I7[0UM/-\0;4QQLRC34Y
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M?#_@7CX@^&B?^@K:_P#HU:^X* "L_7O^1=U/_KTE_P#0#6A6?KW_ "+NI_\
M7I+_ .@&@#X0K[+^$IS\*_#_ /U[G_T-J^-*^R_A+_R2OP__ ->Y_P#0VH [
M2O//C?=?9OA-JR[MK3-#&OO^]4D?D#7H=>2?M$W B^'=M%GF;4(Q^2.?Z4 ?
M+]O$9[F*$=9'"C\3BOOF-!'$B#HJ@5\(Z(8QK^FF=PD0NHM[G^%=XR:^P_\
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MK]Y[*91]2AKX3H *]Y_9H_X_O$@_Z9V_\Y*\&KW;]FG/]J^(1_TPA_\ 0FH
M^B:*** "BBB@ HHHH **** "O$_VD_\ D5M&_P"OUO\ T U[97B?[2?_ "*V
MC?\ 7ZW_ * : /FROL_X5_\ )+_#W_7H/YFOC"OL_P"%?_)+_#W_ %Z#^9H
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MEP?0T .\Z3^^?SH\V3^^?SIN#Z&C!]#0 [S9/[Y_.D,CL,%B0:3!]#1@^AH
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MXW_H;5T=<YX"_P"1(TO_ '&_]#:NCKY^M_$EZL]"'PH****S*"BBB@ HHHH
M^:_VDO\ D:]'_P"O$_\ H9KSSX;_ /)2O#G_ &$(O_0A7H?[27_(UZ/_ ->)
M_P#0S7GGPW_Y*5X<_P"PA%_Z$* /M>BBB@ KYY_:7;_3O#B9Z13G'XI7T-7S
MK^TM_P A;P_Z^1-_Z$M 'EO@+3+;6?'6CZ;=@FWN+@(X'T-?2/\ PI#PK_SS
MDZYZU\[?#,D?$SP[C_G^C_G7VI0!YI_PI#PKC_5R],=:7_A2/A7.?+DZYZUZ
M510!YI_PI#PKC'ER]N]+_P *0\*_\\Y/SKTJB@#S3_A2'A7'^KE_.O0-*TZ'
M2-)L]-M\^1:0I#'GKM4 #^56Z* /G[]IEOWGAE?1;H_^BO\ "O)/ ",_Q%\-
M!1D_VG;M^ D4G^5>H_M+.QUG0(R?E6WE8#W++G^0KS;X9D_\+,\.?]?T?\Z
M/M2BBB@ HHHH **** "N,^+/_)+/$'_7L/\ T):[.N,^+/\ R2SQ!_U[#_T)
M: /C.OIW]G&U$?@34+DIAYM19<^JK&F/U+5\Q5]>_!&V%O\ ";1SMPTIFD;W
MS*X'Z 4 >A4444 %%%% 'P_XZ.?B%XE/_45NO_1K5] _LX_\D\O_ /L*R?\
MHJ*OG[QT<_$+Q*?^HK=?^C6KZ!_9Q_Y)Y?\ _85D_P#145 'K]%%% 'S+^TA
M_P COI?_ &#5_P#1DE>.1H9)%0#EB%'U->Q_M(?\COI?_8-7_P!&25YGX1M5
MOO&>A6C_ ')]0MXV^AD4'^= 'V_96XM+"VMATAB6,8]@!4]%% !1110!Y]\;
MO^21:W];?_T?'7R#7U]\;O\ DD6M_6W_ /1\=?(- 'W_ $444 ?)7QWDW_%:
M_7G]W! O_C@/]:N_L])N^)3MC[EA*?I\R#^M9'QM8GXNZV"<X\@#_OQ'70?L
MYH6^(%\PZ+IKY_[^1T ?3]%%% !1110 5X;^TK &T/0;C:<QW,B!NPW*#C_Q
MW]*]RKQS]H],^ ]-DS]W4T7'UBD_PH ^<=&G^S:WI\X.#%<QOD]L,#7WC7P%
M&<2H?]H5]^T %?(/QM_Y*SK'TA_]%)7U]7R#\;?^2LZQ](?_ $4E '<_LS_\
M??B0?],[?^<E?0M?/7[,_P#Q]^)!_P!,[?\ G)7T+0!QGQ:D,?PK\0,#C-N%
M_-U']:^,Z^P_C/(8_A-KF!G<L2_G*E?'E 'VM\-HEA^&OAQ5Z&PB;\2N3^IK
MJ:YSX?\ 'PY\-X_Z!EO_ .BUKHZ "BBB@ HHHH ^%/$L/V;Q5K$''[J]F3CV
M<BO=OV:7SI/B"/\ NSPM^:M_A7B/C,;?'7B 8QC4KG_T8U>R?LSR<>)(L_\
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MKX!/X<BNJH **** "BBB@ JCK/\ R M0_P"O:3_T$U>JCK/_ " M0_Z]I/\
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M#XHV\9_Y;VLT8_ ;O_9: /K"BBB@ HHHH **** "BBB@ KQ/]I/_ )%;1O\
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MX>B/.VY\[_OA6?\ ]EKLOVD/^1WTO_L&K_Z,DKG_ (&PF7XM:4X_Y91SN?\
MOTZ_^S4 ?75%%% !1110!Y]\;O\ DD6M_6W_ /1\=?(-?7WQN_Y)%K?UM_\
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M&'_T)Z /=O$?_(KZMG_GRF_] -?"=?=GB/\ Y%?5L_\ /E-_Z :^$Z /J_X
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MX.T4>MC"?S0&MFLOPT@C\*Z.BYVK90@9_P!P5J5\[4^-GHQV04445 PHHHH
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M HHHH \^^-W_ "2+6_K;_P#H^.OD&OK[XW?\DBUOZV__ */CKY!H ^_Z***
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MQ_J[J1,_[R9_]EKYPH ^_@0R@CH1D4M4=&NEO="T^[0Y6>VCE!]0R@_UJ]0
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MG\"YC%\6-,3_ )ZQSH?^_3'^E 'US1110 4444 %>/?M'L/^%?Z>O<ZK&?\
MR%+_ (U[#7B7[2<^WPQHMOD?/>L^/7:A'_LU 'S?&,RH/5A7W[7P=HMO]KU[
M3K;_ )[7,<?YL!7WC0 5\@_&W_DK.L?2'_T4E?7U?(/QM_Y*SK'TA_\ 124
M=S^S/_Q]^)/^N=O_ #DKZ%KYZ_9G_P"/OQ)_USM_YR5]"T <1\7EW?"G7Q_T
MQ0_E(IKXWK[5^)<)G^&?B-%&2+&1_P#OD9_I7Q50!]H?"R83_"_P\X;=BT"9
M_P!TD?TKKZX'X*N9/A'H1/4"<?E/(*[Z@ HHHH **** /A_QS(9?'_B)SU.I
M7'_HQJ]A_9GBX\22X_Y]US_W\KQ;Q5*L_B_6IE^[)?SL,^AD8U[G^S3&1I/B
M"3'#3PKGZ*W^- 'NA&5(]17P#7W_ %\%:E;_ &35;RVQCR9WCQ]&(H ^E/V<
M'!\ :BF?F&J.2/8Q1?X&O8:\-_9JN=VA:]:_\\[F.3_OI2/_ &2O<J "BBB@
M KP#]IF0X\,1 \'[4Q'_ 'ZQ_6O?Z^:_VDKDOXJT>USQ%9&3'IN<C_V6@#S/
MP*<?$'PT?^HK:_\ HU:^X*^'_ O_ "4'PUG_ *"MK_Z-6ON"@ K/U[_D7=3_
M .O27_T UH5GZ]_R+NI_]>DO_H!H ^$*^R_A*<_"OP__ ->Y_P#0VKXTK[+^
M$O\ R2OP_P#]>Y_]#:@#M*\"_:90F+PQ)V5KI3^/E?X5[[7B7[2<.[PSHLV/
MN7C)GZH3_P"RT ?-M?=WA^[&H>&]+O0<BXLXI0?7<@/]:^$:^U?AI>)?_#3P
MY,AR%L8X3]8QL/ZJ: .JHHHH **** "BBB@ HHHH **** /*?CCX)77_  K+
MK-K'F_TV/S#@<O&#\P_ $G\*^5NU??LD:2Q/'(H9'!5E(X(/45\2>.O#X\+^
M-M5T=?\ 503$Q?\ 7-@&7]"* .R_9_U4V/Q*6T/W=0M98?H5'F _^.$?C7U7
M7Q5\-+QK'XE^'9E;;F]CC)]G.P_HQK[5H **** "J.L_\@+4/^O:3_T$U>JC
MK/\ R M0_P"O:3_T$T ?!U%%% 'O7[,__'YXD_ZYV_\ .2OH6OGK]F?_ (_/
M$G_7.W_G)7T+0 5\A?&W3&TWXIZFQ7$=VL=S'[AE )_[Z5J^O:^=?VE-*V:K
MH>KJO^N@>V<^FQMR_P#H;?E0!X55BPNY-/U&VO83B6WE65#Z%2"/Y57H[4 ?
M?=O.ES;13Q-NCE0.I'<$9%25R'PLU+^U?ACH%P3EDM1 V?6,E/\ V6NOH *^
M<_VE;()K6@W_ 'FMY83_ , 8'_VI7T97BW[2.GB;PEI.H8R]M>F+/HKH2?U0
M4 ?--%%% 'VM\-[Y-0^&WAV=#D"PBB)_VD&P_JIKJ:\N^ .H?;/AC#;DY-G=
M2PX] 3O_ /9S7J- !1110 4444 %%%% !7B?[2?_ "*VC?\ 7ZW_ * :]LKQ
M/]I/_D5M&_Z_6_\ 0#0!\V5]G_"O_DE_A[_KT'\S7QA7V?\ "O\ Y)?X>_Z]
M!_,T =A2.BR(R,,JPP1ZBEHH ^![VV>RO[BTD&'@E:-A[J<'^505T_Q&LWL?
MB1XCA<8)U":0#V=BX_1A7,4 =[KNL"Y^#'A+3E/_ ![WUZKCW!5Q^DU<%5A[
MV:338+!F_<0S23(/1G"!OTC6C3[1[_4K6SCY>XF2)?JQ '\Z /M[PC92:=X,
MT.RF7;+;Z?!%(/1EC4']:V:.@P** (+W_CQN/^N3?RKX'K[XO>;&X'_3)OY5
M\#T %?5/[/7_ "31_P#K_E_]!2OE:OJC]GH8^&C^]_+_ .@I0!ZO1110 444
M4 %%%% !7S?>2FXU"ZG."99Y)"?JQ/\ 6OHNYE\FUFE_N(S?D*^;%Y .#SS7
MI9>OB?H<V(Z"\^@HVY(7 Y('ZT?@:EM5W7MLNT\S(/\ QX5Z1S'TA&-L2+Z*
M!3J**^;/2"BBB@ HHHH **** /FO]I+_ )&O1_\ KQ/_ *&:\\^&_P#R4KPY
M_P!A"+_T(5Z'^TE_R->C_P#7B?\ T,UYY\-_^2E>'/\ L(1?^A"@#[7HHHH
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MBY^%MM%G/V:YFB/MEM__ +/7IU>,_LWW*OX*U2U_BBU$R'Z-&@'_ * :]FH
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M-TK[-XRT[4UC"QWMGL+#^)XV.?\ QUDKZ:KPK]I:VW:5X>NN\<\T?_?2J?\
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M?<% !6?KW_(NZG_UZ2_^@&M"L_7O^1=U/_KTE_\ 0#0!\(5]E_"7CX5^'_\
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M*** />OV9_\ C\\2?]<[?^<E?0M?/7[,_P#Q^>)/^N=O_.2OH6@ I&571D8
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M_P!*\/H ^VOA_P"(D\4>!]+U16S*T(CG'I(ORM^HS]"*Z6OGW]G3Q/'']O\
M#4[@,[_:8,GJ< ,/T%?05 !1110 4444 %?%'Q&TLZ/\1M>LC@ 7;2+_ +K_
M #K^C"OM>OF/]HO1OL?C.QU6.+;'?VH5W_O21G!_\=*?E0!Y1I6HS:1J]GJ5
MOCSK2=)DSZJ01_*ONG3+^'5=+M-0MSF&YA65/HPS7P4>M?4_P#\3C6?!3:5,
M^;G2W$8!/)C;)4_H1^% 'K%%%% !1110 5QGQ9_Y)9X@_P"O8?\ H2UV=<9\
M6?\ DEGB#_KV'_H2T ?&=?=^A?\ (O:;C_GUB_\ 0!7PA7W?H7'A[30/^?2+
M_P! % &A1110 4444 ?$'CK_ )*%XEQ_T%;K_P!&M7T!^SC_ ,D\O_\ L*R?
M^BHJ^?\ QUQ\0O$H'_05NO\ T:U?0'[./_)/+_\ ["LG_HJ*@#U^BBB@#YE_
M:0_Y'?2_^P:O_HR2L_\ 9\_Y*8?^O&7^:UH?M(?\COI?_8-7_P!&25G_ +/G
M_)3#_P!>,O\ -: /JJBBB@ HHHH \^^-W_)(M;^MO_Z/CKY!KZ^^-W_)(M;^
MMO\ ^CXZ^0: /O\ HHHH YSQ]I_]J?#_ %^S"%W>QE9%'4NJEE_4"OB.OOX@
M$8(R#UKX5\1Z0V@>)=2TAV+&SN7A#'^( D _B,&@#Z9^ .K"_P#AK'9EAOT^
MYDAQWVL=X/\ X^1^%>I5\V?LXZV+;Q)JFC.<+>0":/G^*,]/Q#'\J^DZ "BB
MB@""\NH[&QN+N8XB@C:5SZ!1D_RKX/OKR34+^XO)CF6XE:5SZLQR?YU]=?&3
M7(]$^&>J9DVS7JBTA'=B_#?^.[C7Q[0!]-?LXZ8+?P7J.HE2)+N]V GNB*,?
MJSU[+7&_"G3#I/PPT&W88=[?SVR.<R$O_)A794 %?(/QM_Y*SK'TA_\ 125]
M?5\@_&W_ )*SK'TA_P#124 =S^S/_P ??B3_ '+?^<E?0M?/7[,__'WXD/\
ML6_\Y*^A: "OF+]HS3C;^.;&_5,)=V(!/JZ,P/Z%*^G:\5_:0TLW'A72M35<
MFTNS&Q]%D7_%!0!XI\-M5.B_$;0;W("B[6)R>RR9C8_DQK[5KX"CD:*5)$.'
M1@RGT(K[D\)Z[%XF\*:;K$)&+F!6<?W7Z,/P8$4 ;-%%% !7@O[2NK%;30M&
M5AAY)+J0=QM 5?\ T)_RKWJOD3XVZXFM_$R^$+[X;%%M%(Z97);_ ,>9A^%
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MZ] P'Y U] 4 %%%% !1110 45C^&/$5EXGT.WU*SD5@Z_.H/*L/O#\#FMB@
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M&_$UZ+\)8<WNJS^D<:?F6/\ 2EBG:C(*7QH]2HHHKPCN"BBB@ HHHH ****
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MS]>_Y%W4_P#KTE_] - 'PA7V7\)3GX5^'_\ KW/_ *&U?&E?9?PE.?A7X?\
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M4 >D?LS_ /'YXD_ZYV_\Y*^A:\4^ OA?4O#MUKK7\6Q9DA"<=<%\_P Z]KH
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MXW'_ %R;^5? ]??-TI>SG0<EHV _*OC@?#+Q$1_QZG\J .-KZI_9Z_Y)H_\
MU_R_^@I7A'_"LO$7_/L?RKZ&^">C7FA> WL[Z/9*;V1P/8A1_0T >CT444 %
M%%% !112$X!)[4 >!^+[@W/C'5I<_P#+P4_[Y 7_ -EK%S[BI[N<W5]<W!P?
M-F=\^N234'X"OHX*T4CSF[NX?B*]2^$L1&GZI/V>=$_)<_\ LU>6\^@KV#X6
M0F/PK-(1Q-=NP^@"K_-37-C7:BS6BO?.WHHHKQ3L"BBB@ HHHH **** /FO]
MI+_D:]'_ .O$_P#H9KSSX;_\E*\.?]A"+_T(5Z_\=?">J^(?$VF36,)>..S*
MDX[[R?ZBN)\#_#_7M.\=Z%>36Y$4-]$[G'0!LF@#ZNHHHH **** "O(OCEX#
M;Q!H@UNPBW7]D '51S)'G'Z9S^%>NTCJKHR, 588(/<4 ? -%>W_ !:^$<MA
M<3Z[H<.;5LR30J/N$D !17B<T,EO*T4R,DBG!5A@B@!\5Y<P+MAN)8U]$<BG
MMJ-ZPPUW.0>QD-5J* -+0LGQ)IA)R3=Q<_\  Q7W;7PSX7L+N\\1::;>WDD"
MW<62JY ^<=:^YJ "BBB@#P[X_>!FO[6'Q/80YFMT9+L*.J 9#?AAOSKYQK[[
MN((KJVEMYXUDAE0HZ,.&4C!%?+WQ0^$UYX?OI]4TJ)IM.E<':HRRNQ8X ]!Q
M0!Y+VS5B.^NXD"1W4R*.@5R!4+HT;E'4JPZ@]J;WH GDO;J9=LMS,Z^C.2*]
MI_9K_P"1AUS_ *]$_P#0Z\/KWC]G#3[N#6=:N98'2%K6,*S+C<2Q(Q^1H ^A
MZXSXL_\ )+/$'_7L/_0EKLZY7XE6,^I_#K6K.U7=-+  H]?F!H ^*J^[]"_Y
M%[3,_P#/I%_Z *^0C\,_$0&?LI_*OL#1HWAT/3XI!B1+:-6'N%&: +M%%% !
M1110!\/^.L_\+"\2YZ_VK=?^C6KZ!_9Q_P"2>7__ &%9/_145>5>+?A[KU_X
MTUZ[AMB8Y]1N)$..H,C$5[/\#=#O?#_@F\M+Z/9*^HO(![&.,?S!H ]-HHHH
M ^9?VD/^1WTO_L&K_P"C)*S_ -GS_DIA_P"O&7^:UUOQT\(ZMXA\7Z?<6,)>
M)+!4)Q_%YCG^HJE\%_!NKZ#X_%W>P%(C9RKG'<E: /HJBBB@ HHHH \^^-W_
M "2+6_K;_P#H^.OD&OLKXM:;<:O\,]5L;1"\\K0!0/:9#_2OF9OAGXB52?LI
MX]C0!]G4444 %5M1L(-4TRZT^Z0/;W,312+ZJPP:LT4 ?$'C3PQ<^$?$]UI5
MPI 4[XFQPZ$G!'Y$?A6 K,C!D8JP.00>17UU\6/AXOC715FM$4:K;8$+?WEW
M<J?8 L:^3K^PN=-N6M[J%XI%)&&&,X- &A;>*=7M+":SCO9?+FQNRYSP<UE3
M7$UPV^:5Y&Z9=B:B[8I\4;RR".-"[L<*H')H =;6\MW=16T"%YI7"(HZLQ.
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MFD!XS]*[NB@#P0_L[*6)&I+C/'RUJ:)\ =-LY]VHS"Z3<#MQCC!X_/%>ST4
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MF@TJT6%&;<>YS]:VJ** "BBB@ HHHH **** &&*-CED4GW%/HHH *\5_:2E
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%<#\5[GR]!LK;.#-<Y/T53_4BN^KR?XKW?F:UI]F#Q!;M*?J[8'_ * ?SKIP
M<;UD9U7:#. _&C_@5'XBCGU%>X<($;EP#G/%?25O"+>UA@7I&@0?@,5\]:/%
M]HUW3(2 RR7D*L!Z&1<_IFOHJO,S!_"CIP_4****\TZ0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *^=_P!I>X#:CX=ML_-'%/(1_O%!_P"RU]$5\O\ [1=R
M)?B!9P _ZG3T!'H2[G^6* .=^"\:R?%O0@RY :9OQ$+D?K7V%7R=\ [?SOBE
M;R8_U%K-)_X[M_\ 9J^L: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KP[Q_<_:_&M]@Y6$)"/P7)_4FO<:^<]5NA?Z
MU?WF<B:XD=3ZJ6.W],5WY?&\W(PKO1(J_@*3!]!1^!H_ UZQR'0^!;<W'C;3
M%V@K&SR'\$;'ZXKW:O'?A?;B3Q7)+C_4VK$?BRBO8J\?'N]6WD=E!>Z%%%%<
M1L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7Q_\:KY;[XK:P4;<D/EPCV*Q
MKD?]]9KZ^DD6*)Y'(5$4LQ/8"OA/7M2.L^(M2U,@C[9=2SX/;<Q./UH ]5_9
MOM3)XSU2ZVY6&PV9]"SKC]%-?3->$_LTV+IIGB#4"/DFFA@4^Z*S'_T8M>[4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTMD8JPU-<$'D?NI* /8J*\F^$/Q/3Q-IZ:3JTX&JQDA78X\X?,V?P4 5ZS0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KRWX]:'?:WX%MQ80M-);7J2M&@R2-K+_[-7J5(RAE*L,@\$4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7#?%.]\CPQ#:*V&N[E5(]57+G]0
MOYUW->1_%2]\[Q!:6:D$6T&]AZ,Y_P %%=.$CS5EY:F=5V@SA/Q%&?<4<^@H
M_ 5[APB_B*]$^$MINO-4O6&=B1PJ?J2S?R6O.OP%>Q?"^U\CPF9R #<W#OGU
M PO_ ++7)C)6HOS-:*O,[6BBBO%.T**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1F"*68@*!DD]J6
MN<\=Z@=/\'WS*VV29?(3'7+\'],U4(N<E%=1-V5SQ;5+XZIJ]Y?]1<3-(O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*RN,J01ZBEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO^\W/Z# _"N/&SY:5NYM1C>5SHJ***\8[ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<IX_UW^QO#DB1/MNKK]U%C
MJ,]3^ KJZ\.\=ZV-9\2RK&^;:TS#'Z$C[QKIPE+VE379&=67+$YD (NT' '
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M*ZU:#\%,>?Y5]35\NZ'_ ,3/]IZ3=_#JUR1_VS#X_P#0:^HJ "BBB@ HHHH
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M'>-_(918ZK!<S+WVJ[(3]"5'YT 9_BCPE;^*?'7Q*>7BXL;*UEM_][[/N_\
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M_P!H*?YM7TCX4O)-1\'Z)?3',MS803.?5FC4G]37SCXJF^T_M,P9Y UBQC_
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MHZ L@8C]:]9\&>%+7P9X>32+21I(ED:3<W4EJN>&[=K3PMI%LPPT-E#&?J$
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MJM;QNY?J&9F&/RQ7USI&DV>AZ7#IUA%Y5M#G8GIDDG]37S+\4MVH?'TV>?\
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MG^E?,OP!O38_%!+9N#=VDT&/<8?_ -DKZ)^($PM_AUXD=O\ H&SK^)C('\Z
M/#/V;82WB_5YL?*EAM)]S(I_]E->H_'*=8OA+JR,>9G@1?KYR-_)37 _LS1
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MKU+QC9C4/!6N6A7=YMA,H'OL./UQ7S[^SC<M'X\U"VWX2;3G.WU99(\?H6H
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M]S';_P".A:3XW,!\(M;!_B-N!_W_ (ZZ_P /:=_9'AO2]-_Y]+2*$_55 /\
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M '\)'_H- 'O]?.W[2R@:IX>?^(PS _@R_P"-?1-?._[2_P#R$?#O_7*?^:4
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MRJ6\8/U,A/\ (5]!T ?'7QBB6+XLZ\JC ,D;?B8D)_G7V!:PBVM(8%  CC5
M![#%?)7Q9MS>_&W5+5>LT]M&/J8HQ7UU0!\?_%=7U3XRZO!%@R2W$,"_7RT0
M?RKZST?3(-%T:RTNU&(+2%84SU(48S]:^6HK9]7_ &CFB \S_B?NQ'^S'(6/
MZ+7UE0 5\KZSNU+]IF,+\VW6K<'/I&4S^BU]45\N^%2FH_M-R.PRIU2\<?\
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M /9?C;_R2'7?^W?_ -'QUPO[-FK1?8]:T=F E\U+E!W((VG^0_.O4_B)I?\
M;/P[UZRV[F:S>1!ZL@WK^JBOD7P=XHNO"'B2WU:VRWEG$D>?OIW'Z4 ?<-%5
M--U*UU?3H+^RE$MO.@=&'<&K= !1110 4444 %%%% '+^/M"_MOPS+Y:YN;0
M_:(<=20#D?B"?QQ7FO@;Q)_86LJKL?L-XRI)GHISPWTY.:]RKP3QCH7]A>(;
MBV Q:SYE@]-I/*_ATKT<')3BZ,CGK)Q:FCWI&5T5U(*L,@CN*6O/_AQXI%Y9
MC1[R3_2H ?*9C]]/\G'X5Z!7%5ING)Q9M&2DKH****S*"BBB@ HHHH ****
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MOXE_1S_2@#*_9MM@OA36+K',E\(\_P"Z@/\ [/7M=>0?LX_\D\O_ /L*R?\
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M_LVD7MP3CRH'?/T4FO*OV<5Q\/;]L<MJDG/MY45>A^-9_LO@77YS_!ITY_\
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MPK]I;_D%>'O^N\W_ *"M=K\$O^20Z'_V\?\ H^2N2_:3@+>&=%N,<)>,A/\
MO(3_ .RUT7P'G\[X56*9SY,\R?3YRW_LU 'I=?'OBLG6_CC>1 [S-K*6X_!U
M0?RK[ DD2*-I)&"H@+,Q/  ZFOD3X;1?\)+\:]/N95.)+V6^; Z%0T@_\> '
MXT ?7M?+GPRD&I?M!S7AYWW-[/\ ]]!_\:^HF8(C,QP%&37RU^SW";GXF33,
M<M%82RY/J61?_9J /J:BBB@ HHIBRHTCQJX+IC<H/(STH ?114%[=16%C<7D
MQQ%!$TKGT51D_P J /DT![K]HDXY8>)^WHMQ_@*]W^-\HC^$>LJ3@R- H_[_
M "'^0->#_"02ZW\9--NY@7<S374K'UV.V?\ OHBO9?VA)S#\-!&/^6U]$A^F
M&;_V6@"A^SA;A/ ^IS]Y-29/^^8T_P#BJ]4UV[%AX>U*\)P+>UEESZ;4)_I7
MGO[/]K]G^&$<F,?:+R:3ZXPG_LM=?\0)1#\.O$C'H=,N%_.-A_6@#PO]FZ(G
MQCJTN.%T_;GZR+_A7TO7SW^S/"K7/B68CYD2V0?0F0G_ -!%?0E 'ROX:C-Y
M^TQ+CY@-:O'!]E,A_I7IW[1'_)-X/^PC%_Z!)7F'PC)U'XZ"]Z_O+N<_\"5Q
M_P"S5ZE^T,A?X:QL.B:A$Q_[Y<?UH A_9TS_ ,*ZO,]]3D_]%Q5Z[7D'[.)S
M\/+\9Z:K)_Z*BKT;Q;J']E>#]9O]VTP64KJ?]H*<?KB@#YE^%<YUGXXV=\P_
MUUS<W1S[HY_K7U/J]Q]DT6^N?^>5O))^2DU\N? *W,WQ0@<?\L+6:0_B O\
M[-7TAXY<Q_#_ ,2.IVLNEW)!]#Y34 >#_LW6^[QCJUS_ ,\]/\O_ +ZD4_\
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M?_P&D  & "*7CWKW*<(TX\L3BE)R=V'X4?\  :./>CCWJR0Q[48]J/SH_.@
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M[H_YN*R?V<-2$_A+5--+ O:W@E ]%=1C]4->F^,=$/B/P=JVD+CS+JV=8\]
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MSXJ^(O#MK)!%-]H5QC,ISM^E<UJ.I:GXHU<RSM)<W,KG8G7&23@4 >O?LX:
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M^2$T ?.?[.ZK-\2+Z1QEETV5U]B9(A_(FO6/CK;-/\*=0=1GR9H9#]/, _\
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M/U- 'VA17#_#KQM)XX_MJ\1 MC;W2Q6W'S$;<G/YBNXH *\3^$7Q$BDU*_\
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MT?;?*SQC;LW_ /Q==W10 5YE>?"2*\^(Z^+9+\[UO8[KRMO]S;@?^.UZ;10
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMZ:OJL?S*<P0L/ND?Q?B*].  &!P!7F8S$W_ '</F=-&E]IA1117FG2%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "J.H:19:E;R0W$",'&"=HS^=7J*:;3N@M<\UUCX6QN
M1_9,H@'??S7%ZAX2UJPN/*6TDG'/SJ..*]^IDGW6^E=E/&U(Z/4QE1B]CYPE
MMKBVXGB,?^\*B_$5U/C/_7C_ 'U_] KE!_G\J]6$N:-SEDK.P[GU%+^(I@ZC
M\*0=/P'\ZLD?SZBI(X9IVQ"A=O0?I4/^?UK>\*_\?[?[R?S-3-\L;C2NRO:^
M&]:O)UC6QD16Q\Y''7_Z]=CI'PND\X/JDZR0D9V+P17HNF_\>,7^Z/Y5=KRJ
MF-J/1:'5&A%;F3I/AS3=&MUAM;==J]"PR:UJ**XI2<G=FR26P4444AA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
A110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 23!/\# 2(  A$! Q$!_\0
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M_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\ )7M"_P"WC_T1
M)7G]>@?!+_DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_\ 1$E>?UZ!\$O^2O:%
M_P!O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KT#X)?\E>T+_MX_]$25Y_7H'P2_Y*]H7_;Q_P"B)* //Z*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_P E>T+_
M +>/_1$E>?UZ!\$O^2O:%_V\?^B)* //Z*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P
M2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O0/@E_R5[0O^WC_ -$25Y_7H'P2_P"2O:%_V\?^
MB)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "O0/@E_R5[0O^WC_T1)7G]>@?!+_DKVA?]O'_ *(DH \_HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_
M "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_ $1)
M7G]>@?!+_DKVA?\ ;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/\ T1)7G]>@?!+_ )*]
MH7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKT#X)?\ )7M"_P"WC_T1)7G]>@?!+_DKVA?]O'_HB2@#S^BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_M
MX_\ 1$E>?UZ!\$O^2O:%_P!O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\
M$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_]$25Y_7H'P2_Y*]H7_;Q_P"B
M)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "O0/@E_P E>T+_ +>/_1$E>?UZ!\$O^2O:%_V\?^B)* //Z*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_
MR5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_ -$2
M5Y_7H'P2_P"2O:%_V\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_T1)7G]>@?!+_DKVA?
M]O'_ *(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*] ^"7_)7M"_[>/_ $1)7G]>@?!+_DKVA?\ ;Q_Z(DH \_HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[
M>/\ T1)7G]>@?!+_ )*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$
MO^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KT#X)?\ )7M"_P"WC_T1)7G]>@?!+_DKVA?]O'_H
MB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KT#X)?\E>T+_MX_\ 1$E>?UZ!\$O^2O:%_P!O'_HB2@#S^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?
M\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_]$25
MY_7H'P2_Y*]H7_;Q_P"B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O0/@E_P E>T+_ +>/_1$E>?UZ!\$O^2O:
M%_V\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O0/@E_R5[0O^WC_ -$25Y_7H'P2_P"2O:%_V\?^B)* //Z*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^
MWC_T1)7G]>@?!+_DKVA?]O'_ *(DH \_HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'
MP2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_ $1)7G]>@?!+_DKVA?\ ;Q_Z
M(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *] ^"7_)7M"_[>/\ T1)7G]>@?!+_ )*]H7_;Q_Z(DH \_HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7
M_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\ )7M"_P"WC_T1
M)7G]>@?!+_DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_\ 1$E>?UZ!\$O^2O:%
M_P!O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KT#X)?\E>T+_MX_]$25Y_7H'P2_Y*]H7_;Q_P"B)* //Z*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_P E>T+_
M +>/_1$E>?UZ!\$O^2O:%_V\?^B)* //Z*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P
M2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O0/@E_R5[0O^WC_ -$25Y_7H'P2_P"2O:%_V\?^
MB)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "O0/@E_R5[0O^WC_T1)7G]>@?!+_DKVA?]O'_ *(DH \_HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_
M "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_ $1)
M7G]>@?!+_DKVA?\ ;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/\ T1)7G]>@?!+_ )*]
MH7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#S^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKT#X)?\ )7M"_P"WC_T1)7G]>@?!+_DKVA?]O'_HB2@#S^BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_M
MX_\ 1$E>?UZ!\$O^2O:%_P!O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_P#1$E>?UZ!\
M$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_]$25Y_7H'P2_Y*]H7_;Q_P"B
M)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "O0/@E_P E>T+_ +>/_1$E>?UZ!\$O^2O:%_V\?^B)* //Z*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_
MR5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_ -$2
M5Y_7H'P2_P"2O:%_V\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^WC_T1)7G]>@?!+_DKVA?
M]O'_ *(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'P2_Y*]H7_;Q_Z(DH \_H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*] ^"7_)7M"_[>/_ $1)7G]>@?!+_DKVA?\ ;Q_Z(DH \_HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[
M>/\ T1)7G]>@?!+_ )*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_1$E>?UZ!\$
MO^2O:%_V\?\ HB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KT#X)?\ )7M"_P"WC_T1)7G]>@?!+_DKVA?]O'_H
MB2@#S^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KT#X)?\E>T+_MX_\ 1$E>?UZ!\$O^2O:%_P!O'_HB2@#S^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?
M\E>T+_MX_P#1$E>?UZ!\$O\ DKVA?]O'_HB2@#S^BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT#X)?\E>T+_MX_]$25
MY_7H'P2_Y*]H7_;Q_P"B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O0/@E_P E>T+_ +>/_1$E>?UZ!\$O^2O:
M%_V\?^B)* //Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O0/@E_R5[0O^WC_P!$25Y_7H'P2_Y*]H7_ &\?^B)* //Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O0/@E_R5[0O^WC_ -$25Y_7H'P2_P"2O:%_V\?^B)* //Z*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O0/@E_R5[0O^
MWC_T1)7G]>@?!+_DKVA?]O'_ *(DH \_HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7_ "5[0O\ MX_]$25Y_7H'
MP2_Y*]H7_;Q_Z(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *] ^"7_)7M"_[>/_ $1)7G]>@?!+_DKVA?\ ;Q_Z
M(DH \_HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *] ^"7_)7M"_[>/\ T1)7G]>@?!+_ )*]H7_;Q_Z(DH \_HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *] ^"7
M_)7M"_[>/_1$E>?UZ!\$O^2O:%_V\?\ HB2@#W__ (4E\//^A>_\G;C_ ..4
M?\*2^'G_ $+W_D[<?_'*** #_A27P\_Z%[_R=N/_ (Y1_P *2^'G_0O?^3MQ
M_P#'*** #_A27P\_Z%[_ ,G;C_XY1_PI+X>?]"]_Y.W'_P <HHH /^%)?#S_
M *%[_P G;C_XY1_PI+X>?]"]_P"3MQ_\<HHH /\ A27P\_Z%[_R=N/\ XY1_
MPI+X>?\ 0O?^3MQ_\<HHH /^%)?#S_H7O_)VX_\ CE'_  I+X>?]"]_Y.W'_
M ,<HHH /^%)?#S_H7O\ R=N/_CE'_"DOAY_T+W_D[<?_ !RBB@ _X4E\//\
MH7O_ "=N/_CE'_"DOAY_T+W_ ).W'_QRBB@ _P"%)?#S_H7O_)VX_P#CE'_"
MDOAY_P!"]_Y.W'_QRBB@ _X4E\//^A>_\G;C_P".4?\ "DOAY_T+W_D[<?\
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M@ _X4E\//^A>_P#)VX_^.4?\*2^'G_0O?^3MQ_\ '*** #_A27P\_P"A>_\
M)VX_^.4?\*2^'G_0O?\ D[<?_'*** #_ (4E\//^A>_\G;C_ ..4?\*2^'G_
M $+W_D[<?_'*** #_A27P\_Z%[_R=N/_ (Y1_P *2^'G_0O?^3MQ_P#'***
M#_A27P\_Z%[_ ,G;C_XY1_PI+X>?]"]_Y.W'_P <HHH /^%)?#S_ *%[_P G
M;C_XY1_PI+X>?]"]_P"3MQ_\<HHH /\ A27P\_Z%[_R=N/\ XY1_PI+X>?\
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MH /^%)?#S_H7O_)VX_\ CE'_  I+X>?]"]_Y.W'_ ,<HHH /^%)?#S_H7O\
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<#5M)T;[/?0;O+E^U3/MW*5/#.0>"1R*** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
